Ophthalmology – Purtscher’s Retinopathy

Basics

Description

Purtscher retinopathy is a rare acute occlusive microangiopathy characterized by sudden visual loss with posterior-pole retinal whitening, classically after severe trauma remote from the eye.

When an identical retinal phenotype occurs without trauma, it is termed:

Purtscher-like retinopathy

Typical fundus findings include:

• Purtscher flecken
• Cotton-wool spots
• Few retinal hemorrhages
• Posterior-pole predominance
• Variable optic disc edema

The disease is usually:

• Bilateral
• Asymmetric
• Acute
• Nonprogressive once the precipitating systemic disorder is controlled

Purtscher vs Purtscher-Like Retinopathy

Purtscher Retinopathy

Traditionally associated with:

• Severe head trauma
• Chest compression
• Long-bone fractures
• Major multisystem trauma

Purtscher-Like Retinopathy

Similar ocular findings associated with systemic disease such as:

• Acute pancreatitis
• Fat embolism syndrome
• Preeclampsia/HELLP
• Thrombotic thrombocytopenic purpura
• Hemolytic uremic syndrome
• Autoimmune disease
• Renal failure
• Amniotic fluid embolism

The retinal appearance is essentially the same.

Epidemiology

Purtscher retinopathy is:

Very rare

and true incidence is uncertain.

Because many patients are critically ill from their systemic disorder, milder ocular cases may go undiagnosed.

Pathophysiology

The leading mechanism is:

Occlusion of precapillary retinal arterioles and capillaries

causing focal inner retinal ischemia.

Several mechanisms may contribute.

Complement Activation

One important proposed mechanism is:

Complement activation → leukocyte aggregation → microvascular occlusion

This is particularly relevant in:

• Pancreatitis
• Severe inflammatory systemic disease

Microembolic Mechanisms

Potential embolic material includes:

• Fat
• Leukocyte aggregates
• Fibrin
• Platelet aggregates
• Air in selected traumatic settings

The exact mechanism may vary according to the underlying disorder.

Why Large Retinal Vessels Look Normal

The occlusion typically occurs at the level of:

• Precapillary arterioles
• Capillary beds

rather than major retinal arteries.

Therefore:

Visible emboli in large retinal vessels are usually absent.

Associated Conditions

Important associations include:

• Severe trauma
• Acute pancreatitis
• Fat embolism syndrome
• Preeclampsia
• HELLP syndrome
• TTP
• HUS
• Systemic lupus erythematosus
• Scleroderma
• Dermatomyositis
• Cryoglobulinemia
• Chronic renal failure
• Amniotic fluid embolism
• Severe systemic inflammatory states

Trauma Associations

Classic traumatic triggers include:

• Head trauma
• Chest compression
• Long-bone fracture
• Polytrauma

Direct ocular trauma should prompt consideration of:

• Commotio retinae
• Traumatic retinal vascular injury

rather than classic Purtscher retinopathy.

Acute Pancreatitis

Acute pancreatitis is one of the best-known causes of Purtscher-like retinopathy.

The proposed mechanism involves:

• Complement activation
• Leukocyte aggregation
• Retinal capillary occlusion

Ocular findings may occasionally precede recognition of severe systemic disease.

Fat Embolism Syndrome

Fat embolism after:

• Long-bone fracture
• Orthopedic trauma

may produce:

• Respiratory distress
• Neurologic changes
• Petechial rash
• Retinal ischemic changes

Purtscher-like retinal findings may overlap with:

Fat embolism retinopathy.

Autoimmune Disease

Purtscher-like changes have been described in:

• SLE
• Scleroderma
• Dermatomyositis

These disorders can independently produce retinal microangiopathy, so clinical context is important.

Clinical Presentation

Typical presentation is:

Acute painless reduction in vision

often developing:

• Within hours
• Within 1–2 days

after the precipitating event.

Laterality

Disease is usually:

Bilateral

but may be:

• Asymmetric
• Rarely unilateral

Visual Acuity

Vision may range from:

• Mildly reduced
• Moderate impairment
• Profound visual loss

Visual loss depends on involvement of:

• Foveal capillary circulation
• Optic nerve
• Extent of retinal ischemia

Visual Field

Possible field defects include:

• Central scotoma
• Paracentral scotoma
• Relative central depression

depending on macular involvement.

Fundus Findings

Classic findings are concentrated:

Posterior to the equator

especially around the:

• Optic disc
• Posterior pole
• Retinal vascular arcades

Purtscher Flecken

Purtscher flecken are the most characteristic finding.

They appear as:

• Polygonal
• White
• Superficial retinal patches

located between retinal arterioles and venules.

A helpful distinguishing feature is:

A narrow zone of retinal whitening that may spare the immediate vessel border

because the ischemia involves the precapillary bed.

Cotton-Wool Spots

Cotton-wool spots are common and represent:

Focal retinal nerve fiber layer ischemia

They may coexist with Purtscher flecken.

Retinal Hemorrhages

Hemorrhages are usually:

• Few
• Small
• Superficial or intraretinal

Extensive hemorrhage should prompt consideration of another diagnosis.

Optic Disc Findings

Possible findings include:

• Mild disc edema
• Peripapillary whitening
• Later optic disc pallor

Severe optic nerve involvement is associated with poorer visual prognosis.

Late Fundus Changes

As acute retinal whitening resolves, later findings may include:

• Optic atrophy
• Retinal arterial attenuation
• RPE mottling
• Inner retinal thinning
• RNFL loss

Diagnosis

Diagnosis is primarily:

Clinical

and depends on:

• Characteristic fundus appearance
• Compatible systemic or traumatic trigger
• Exclusion of other ischemic and inflammatory retinal disorders

Proposed Diagnostic Criteria

A commonly used framework supports the diagnosis when several of the following are present:

• Purtscher flecken
• Few retinal hemorrhages
• Cotton-wool spots confined largely to posterior pole
• Plausible precipitating systemic or traumatic event
• Compatible ancillary investigations

No single finding is completely pathognomonic.

Optical Coherence Tomography

OCT is very useful for documenting acute and chronic structural changes.

Acute Phase

May show:

• Inner retinal hyperreflectivity
• RNFL thickening
• Ganglion cell/inner plexiform edema
• Middle retinal ischemic changes

PAMM-Like Changes

Some eyes demonstrate changes resembling:

Paracentral acute middle maculopathy (PAMM)

with hyperreflectivity involving:

• Inner nuclear layer
• Middle retina

reflecting ischemia of the deep/intermediate retinal capillary plexuses.

Chronic OCT Changes

Later OCT may show:

• Inner retinal thinning
• RNFL loss
• Ganglion cell loss
• Foveal structural damage

These correlate with permanent visual deficit.

OCT Angiography

OCTA may demonstrate:

• Reduced capillary density
• Superficial plexus nonperfusion
• Deep plexus nonperfusion

It is useful for showing retinal microvascular ischemia without dye injection.

Fluorescein Angiography

FA may demonstrate:

• Capillary nonperfusion
• Delayed arteriolar filling
• Vascular leakage
• Late staining of ischemic areas

Findings vary according to disease severity.

Fundus Photography

Photography is useful for:

• Baseline documentation
• Following resolution of retinal whitening
• Comparing hemorrhage and cotton-wool spot burden

Fundus Autofluorescence

FAF is not essential but may show:

• Secondary RPE abnormalities

during later stages.

Laboratory Evaluation

There is no laboratory test that diagnoses Purtscher retinopathy itself.

Testing should instead be directed toward identifying the:

Underlying systemic cause

when not already known.

Systemic Workup

Depending on clinical context, consider:

• CBC
• Platelet count
• Renal function
• Liver function
• Coagulation profile
• Lipase/amylase
• Hemolysis studies
• Autoimmune testing

The exact workup should be driven by:

• Trauma history
• Systemic symptoms
• Pregnancy status
• Medical context

Differential Diagnosis

Important differentials include:

• Central retinal artery occlusion
• Branch retinal artery occlusion
• Commotio retinae
• Fat embolism retinopathy
• Hypertensive retinopathy
• Severe preeclampsia/HELLP retinopathy
• TTP/HUS retinopathy
• Lupus retinopathy
• HIV retinopathy
• Interferon retinopathy
• Retinal vein occlusion
• Valsalva retinopathy
• Terson syndrome
• Abusive head trauma in infants/children

Purtscher Retinopathy vs CRAO

Purtscher Retinopathy

• Usually bilateral
• Patchy polygonal retinal whitening
• Cotton-wool spots
• Few hemorrhages
• Systemic/traumatic trigger

CRAO

• Usually unilateral
• Diffuse retinal whitening
• Cherry-red spot
• Marked arterial attenuation
• Often abrupt profound vision loss

Purtscher Retinopathy vs Commotio Retinae

Purtscher

• Remote body trauma possible
• Usually bilateral
• Posterior microvascular ischemia
• Purtscher flecken

Commotio Retinae

• Direct ocular trauma
• Outer retinal photoreceptor injury
• Gray-white retinal opacity at site of impact
• Usually unilateral

Purtscher vs Valsalva Retinopathy

Valsalva retinopathy produces:

• Preretinal/subhyaloid hemorrhage
• Sudden painless central visual loss

without the characteristic:

• Purtscher flecken
• Cotton-wool spot pattern

Purtscher vs Terson Syndrome

Terson syndrome occurs with:

• Subarachnoid hemorrhage
• Intracranial hemorrhage
• Severe acute elevation of intracranial pressure

and typically causes:

• Vitreous hemorrhage
• Preretinal hemorrhage
• Intraretinal hemorrhage

rather than a primarily ischemic white-retina phenotype.

Treatment

Ocular Treatment

There is:

No proven sight-restoring ocular treatment

for Purtscher or Purtscher-like retinopathy.

Management is primarily:

• Observation
• Documentation
• Treatment of the systemic precipitating disorder

Systemic Treatment

Treat the underlying cause aggressively.

Examples include management of:

• Acute pancreatitis
• Major trauma
• TTP/HUS
• Preeclampsia/HELLP
• Autoimmune disease
• Renal failure
• Fat embolism syndrome

This may prevent further systemic and retinal injury.

Corticosteroids

High-dose corticosteroids have been reported in case series and case reports.

However:

There is no convincing evidence that corticosteroids improve final visual outcome in routine Purtscher retinopathy.

They should not be used solely for the retinal findings unless indicated for the:

Underlying systemic disease.

Anti-VEGF

Anti-VEGF therapy has:

No established role in uncomplicated Purtscher retinopathy.

It may be considered only if a separate VEGF-mediated complication develops.

Laser Treatment

Retinal laser has:

No routine role

because the disease is primarily an acute microvascular ischemic process.

Vitrectomy

Vitrectomy is not a treatment for the retinal ischemia itself.

It may be considered only for an unrelated or secondary surgical indication such as:

• Nonclearing vitreous hemorrhage

which is uncommon in classic disease.

Follow-Up

Initial follow-up depends on:

• Severity of visual loss
• Activity of systemic disease
• Extent of retinal ischemia

Repeat examination may include:

• Visual acuity
• Fundus photography
• OCT
• OCTA
• FA in selected cases

Resolution

Purtscher flecken and cotton-wool spots often fade over:

Weeks to months

but structural retinal damage may remain.

Prognosis

Visual prognosis is:

Variable

Spontaneous improvement is common, particularly when:

• Initial visual acuity is relatively preserved
• Foveal ischemia is limited
• Optic nerve involvement is absent
• Retinal whitening resolves quickly

Poor Prognostic Features

Features associated with worse visual outcome include:

• Severe initial visual loss
• Persistent retinal whitening
• Extensive capillary nonperfusion
• Foveal involvement
• Optic disc swelling followed by atrophy
• Significant inner retinal thinning

Long-Term Visual Outcome

Some patients recover:

• Several lines of visual acuity
• Near-normal vision

while others retain:

• Central scotoma
• Reduced acuity
• Contrast loss
• Permanent visual field defects

Complications

Potential sequelae include:

• Optic atrophy
• Inner retinal atrophy
• RNFL thinning
• Permanent scotoma
• Persistent central visual loss
• Retinal arterial attenuation
• RPE abnormalities

Patient Education

Patients should understand that:

• The retinal process is usually acute rather than continuously progressive
• Vision may improve spontaneously over weeks to months
• Final recovery depends on the degree of retinal and optic nerve ischemia
• Management of the associated systemic illness is essential

Ophthalmology Pearls

• Purtscher retinopathy is an acute occlusive retinal microangiopathy classically following severe trauma remote from the eye.
• The identical retinal phenotype associated with systemic disease is called Purtscher-like retinopathy.
• Major nontraumatic associations include acute pancreatitis, TTP/HUS, preeclampsia/HELLP, autoimmune disease, renal failure, and fat embolism syndrome.
• The characteristic lesion is the Purtscher flecken: polygonal patches of posterior retinal whitening related to precapillary arteriolar occlusion.
• Cotton-wool spots are common, while retinal hemorrhages are usually few rather than extensive.
• Disease is usually bilateral but asymmetric and causes acute painless visual loss.
• The leading mechanism is precapillary microvascular occlusion, potentially involving complement activation, leukocyte aggregation, and microemboli.
• OCT acutely shows inner/middle retinal hyperreflectivity and edema, with later inner retinal and RNFL thinning.
• OCTA and FA can demonstrate capillary nonperfusion.
• There is no proven ocular treatment that reliably restores vision; management focuses on treating the underlying systemic disorder.
• Systemic corticosteroids have been reported but have not demonstrated clear evidence of benefit for the retinal disease itself.
• Purtscher retinopathy should be distinguished from CRAO, commotio retinae, Terson syndrome, Valsalva retinopathy, and fat embolism retinopathy.
• Visual recovery is variable but spontaneous improvement is common; poor prognosis is associated with extensive foveal ischemia, persistent whitening, optic nerve involvement, and subsequent retinal atrophy.
• The disease is generally acute and self-limited rather than chronically progressive, although permanent ischemic damage may remain.

Ophthalmology – Pupillary Block Glaucoma

Basics

Description

Pupillary block is the most common mechanism of primary angle closure.

It occurs when aqueous humor encounters increased resistance while passing:

Posterior chamber → through pupil → anterior chamber

The resulting pressure differential pushes the peripheral iris anteriorly, producing:

Iris bombe → iridotrabecular contact → angle closure → elevated IOP

If prolonged or recurrent, this can lead to:

• Peripheral anterior synechiae (PAS)
• Chronic angle closure
• Glaucomatous optic neuropathy
• Permanent visual loss

Key Clinical Concept

Pupillary block is a:

Mechanism of angle closure

rather than a single disease entity.

It may occur as:

• Acute primary angle closure
• Intermittent angle closure
• Chronic primary angle closure
• Secondary pupillary block

The definitive treatment for a significant pupillary-block component is usually:

Laser peripheral iridotomy (LPI)

which creates an alternative route for aqueous from the posterior to anterior chamber.

Modern Primary Angle-Closure Classification

It is useful to distinguish:

Primary Angle-Closure Suspect (PACS)

• Iridotrabecular contact/occludable angle
• No PAS
• No elevated IOP attributable to angle closure
• No glaucomatous optic neuropathy

Primary Angle Closure (PAC)

Angle closure with evidence such as:

• PAS
• Elevated IOP

but:

• No glaucomatous optic neuropathy

Primary Angle-Closure Glaucoma (PACG)

PAC plus:

Glaucomatous optic nerve and/or visual field damage

Epidemiology

Primary angle-closure disease is more common in:

• East and Southeast Asian populations
• Inuit populations
• Older adults
• Women

It is less common in many European-derived populations.

Risk rises substantially with age because the crystalline lens:

• Thickens
• Moves anteriorly
• Crowds the anterior segment

Risk Factors

Important risk factors include:

• Increasing age
• Female sex
• Asian or Inuit ancestry
• Hyperopia
• Short axial length
• Shallow anterior chamber
• Thick or anteriorly positioned lens
• Small corneal diameter
• Family history
• Plateau iris configuration
• Nanophthalmos

Lens-Related Predisposition

The crystalline lens plays a major role in angle closure.

With age it becomes:

• Thicker
• More anteriorly positioned

This narrows the space between:

• Iris
• Lens
• Cornea

and increases resistance to aqueous movement through the pupil.

Genetics

Primary angle-closure disease has significant:

Heritability

and first-degree relatives have increased risk.

The genetics are:

• Polygenic
• Complex
• Influenced by ocular biometric traits

Routine genetic testing is not clinically useful.

Pathophysiology

Normally, aqueous humor flows:

Ciliary body → posterior chamber → pupil → anterior chamber → trabecular meshwork

In relative pupillary block:

• Iris contacts the anterior lens more tightly
• Resistance to aqueous movement through the pupil rises
• Posterior chamber pressure exceeds anterior chamber pressure
• Peripheral iris bows forward

This produces:

Iris bombe

Iris Bombe

Iris bombe is anterior convexity of the iris caused by:

Posterior chamber pressure exceeding anterior chamber pressure

The peripheral iris then contacts:

• Trabecular meshwork
• Peripheral cornea in severe cases

causing acute or chronic closure of the drainage angle.

Appositional vs Synechial Closure

Appositional Closure

The iris contacts the trabecular meshwork but:

• Can still be mechanically separated

This may reverse with:

• Indentation
• Resolution of pupillary block
• LPI

Synechial Closure

Prolonged contact causes:

Peripheral anterior synechiae

which represent permanent adhesions between iris and angle structures.

Peripheral Anterior Synechiae

PAS can lead to:

• Persistent angle closure
• Chronic IOP elevation
• Reduced response to LPI alone

Greater PAS burden generally predicts:

Greater likelihood of persistent glaucoma after LPI.

Acute Primary Angle Closure

An acute attack occurs when the angle suddenly closes extensively, causing rapid IOP elevation.

Typical symptoms include:

• Severe ocular pain
• Red eye
• Blurred vision
• Halos around lights
• Frontal headache
• Nausea
• Vomiting

This is an:

Ophthalmic emergency

Precipitating Factors

Acute angle closure may be precipitated by pupillary dilation from:

• Darkness
• Emotional stress
• Pharmacologic mydriasis
• Anticholinergic medications
• Sympathomimetic medications

The pupil is often most vulnerable in a:

Mid-dilated position

because iridolenticular contact and peripheral iris crowding increase.

Medication-Associated Angle Closure

Drugs that may trigger pupillary-block angle closure in anatomically narrow eyes include:

• Anticholinergics
• Sympathomimetics
• Some inhaled anticholinergics
• Some antidepressants through pupillary dilation

Important Modern Distinction – Topiramate

Topiramate-associated angle closure is generally caused by:

Ciliochoroidal effusion with forward rotation of the ciliary body

not pupillary block.

Typical features include:

• Bilateral acute myopic shift
• Bilateral shallow chambers
• Angle closure

Treatment involves:

• Stopping the causative medication
• Cycloplegia
• IOP lowering
• Steroids in selected cases

and:

LPI is usually ineffective because the mechanism is not pupillary block.

Secondary Pupillary Block

Pupillary block can also result from:

• 360° posterior synechiae (seclusio pupillae)
• Uveitis
• Intumescent cataract
• Spherophakia
• Lens subluxation
• Aphakia with vitreous block
• Pseudophakic pupillary block
• Silicone oil
• Gas tamponade in selected circumstances

Uveitic Pupillary Block

Inflammation can produce:

Posterior synechiae

If synechiae become circumferential:

Seclusio pupillae → iris bombe → secondary angle closure

Management may require:

• Intensive topical corticosteroids
• Cycloplegia
• LPI or surgical iridectomy

Lens Subluxation and Spherophakia

A small spherical or anteriorly displaced lens can:

• Increase iridolenticular contact
• Produce pupillary block
• Cause angle closure

Lens extraction may ultimately be required.

Clinical History

Ask about:

• Eye pain
• Halos
• Blurred vision
• Intermittent attacks in dim lighting
• Headache
• Nausea/vomiting
• Previous similar episodes
• Family history of angle closure
• Hyperopia
• Recent dilation
• New medications
• Prior uveitis
• Cataract
• Ocular surgery

Intermittent Angle Closure

Before a full acute attack, patients may report recurrent episodes of:

• Blurred vision
• Colored halos
• Brow ache
• Mild headache

especially in:

• Darkness
• Evening
• Stress

Symptoms may resolve spontaneously as the pupil constricts.

Examination in Acute Angle Closure

Typical findings include:

• Conjunctival/ciliary injection
• Corneal edema
• Very shallow peripheral anterior chamber
• Markedly elevated IOP
• Mid-dilated poorly reactive pupil
• Closed angle
• Possible anterior chamber cells
• Glaukomflecken after severe/prolonged attack

Corneal Edema

Marked IOP elevation causes endothelial dysfunction and:

Microcystic corneal edema

This may:

• Reduce visual acuity
• Produce halos
• Obscure gonioscopy
• Make LPI difficult

Pupil

The pupil is often:

• Mid-dilated
• Sluggish
• Poorly reactive

because severe IOP elevation causes:

Iris sphincter ischemia

Glaukomflecken

Glaukomflecken are small anterior subcapsular lens opacities caused by acute lens epithelial ischemic injury after a severe IOP spike.

They suggest:

Previous acute angle closure

and may remain permanently visible.

Gonioscopy

Gonioscopy is essential in the diagnosis of angle-closure disease.

Assess:

• Degree of angle narrowing
• Iridotrabecular contact
• PAS
• Pigmentation
• Plateau iris configuration
• Other secondary mechanisms

Indentation Gonioscopy

Indentation gonioscopy helps distinguish:

Appositional closure from PAS

If the angle opens with indentation:

• Closure is predominantly appositional

If it remains closed:

• PAS or another fixed structural mechanism is likely

Fellow Eye Examination

The fellow eye should be examined carefully because it often has similar:

• Biometry
• Angle anatomy
• Predisposition to acute closure

The fellow eye may require:

Prophylactic LPI if it remains anatomically occludable.

Intraocular Pressure

IOP during acute primary angle closure may become extremely high, often:

40–70 mmHg or higher

but the exact pressure varies.

Chronic PACG may have:

• Persistently elevated IOP
• Intermittent elevation
• Normal IOP between attacks

Optic Nerve Examination

After the acute attack is controlled, assess:

• Cup-to-disc ratio
• Rim thinning
• RNFL loss
• Disc hemorrhage

because the patient may already have:

Chronic glaucomatous damage.

Visual Fields

Obtain automated perimetry after:

• Cornea clears
• IOP stabilizes
• Acute symptoms resolve

to assess for:

• Arcuate defects
• Nasal step
• Advanced constriction

OCT

OCT may assess:

• RNFL
• GCIPL/GCC
• Glaucomatous optic neuropathy

Anterior segment OCT can also demonstrate:

• Angle width
• Iris configuration
• Lens-related crowding

Ultrasound Biomicroscopy

UBM is particularly useful when the mechanism is uncertain.

It can demonstrate:

• Plateau iris
• Ciliary body anatomy
• Lens position
• Ciliary body cysts
• Supraciliary effusion
• Anterior rotation of ciliary body

Provocative Testing

Historical tests include:

• Dark-room prone testing
• Pharmacologic dilation testing

These have limited diagnostic accuracy and are:

Not routinely recommended

because modern:

• Gonioscopy
• AS-OCT
• UBM

provide safer and more useful anatomic information.

Differential Diagnosis

Important alternatives include:

• Plateau iris syndrome
• Phacomorphic glaucoma
• Neovascular angle closure
• Uveitic glaucoma
• Aqueous misdirection
• Topiramate/sulfonamide-induced ciliochoroidal effusion
• Lens subluxation
• Choroidal effusion
• Suprachoroidal hemorrhage
• Posterior segment mass

Pupillary Block vs Plateau Iris

Pupillary Block

• Iris bombe
• Increased iridolenticular resistance
• Usually relieved by LPI

Plateau Iris

• Relatively flat central iris
• Anteriorly positioned ciliary processes
• Peripheral iris rises abruptly
• Angle may remain occludable despite patent LPI

Pupillary Block vs Phacomorphic Glaucoma

Phacomorphic glaucoma involves:

• Intumescent/thickened lens
• Shallow central and peripheral chamber
• Lens crowding plus pupillary block

Definitive treatment is:

Cataract extraction

after acute IOP control.

Pupillary Block vs Aqueous Misdirection

Aqueous misdirection usually causes:

• Uniformly shallow or flat central and peripheral chamber
• Often postoperative setting
• Patent iridotomy

The iris configuration is different from classic iris bombe.

Acute Treatment Goals

Management of acute primary angle closure has three goals:

1. Rapidly lower IOP
2. Reduce inflammation and symptoms
3. Eliminate pupillary block definitively

Initial Medical Therapy

Common acute treatment includes:

• Topical beta-blocker
• Topical alpha-2 agonist
• Topical carbonic anhydrase inhibitor
• Systemic acetazolamide

A typical adult acetazolamide loading dose is often:

500 mg

unless contraindicated.

Hyperosmotic Therapy

If IOP remains very high or the attack is severe, consider:

• IV mannitol
• Oral glycerol in selected patients

Hyperosmotic agents reduce vitreous volume and help:

• Deepen the anterior chamber
• Lower IOP

Use carefully in patients with:

• Heart failure
• Renal impairment
• Significant volume-status problems

Topical Steroids

Topical corticosteroids are useful because acute angle closure produces:

Significant anterior segment inflammation

They help reduce:

• Cells/flare
• Pain
• Synechial formation

Pilocarpine

Pilocarpine can constrict the pupil and pull the peripheral iris away from the angle.

However:

Do not rely on pilocarpine while IOP is extremely high.

At very high IOP:

• Iris sphincter becomes ischemic
• Pilocarpine may be ineffective

It is typically used after IOP begins to fall.

Important Pilocarpine Exceptions

Pilocarpine may be inappropriate or harmful in angle closure caused by:

• Topiramate/ciliochoroidal effusion
• Aqueous misdirection
• Certain lens-induced mechanisms

because further anterior movement or ciliary-body contraction can worsen crowding.

Analgesia and Antiemetics

Patients often require:

• Analgesics
• Antiemetics

because nausea and vomiting can be severe.

Anterior Chamber Paracentesis

Anterior chamber paracentesis can produce:

Rapid IOP reduction

and may be considered by an experienced ophthalmologist when:

• IOP is dangerously high
• Medical therapy is inadequate
• Rapid corneal clearing is needed

It is an:

Adjunct, not a substitute for definitive treatment.

Corneal Indentation

Gentle indentation of the central cornea may sometimes temporarily:

• Force aqueous toward the angle
• Open appositional closure
• Reduce IOP

This is a short-term maneuver only.

Definitive Treatment – Laser Peripheral Iridotomy

LPI is the definitive treatment for pupillary block.

The iridotomy creates a direct channel between:

• Posterior chamber
• Anterior chamber

which equalizes pressure and flattens iris bombe.

Timing of LPI

LPI should be performed once:

• IOP is sufficiently controlled
• Cornea is clear enough
• Inflammation permits safe laser treatment

Iridotomy Site

LPI is usually placed:

• Superiorly or superotemporally

under the upper lid when possible.

Modern placement is individualized to:

• Iris crypts
• Lid position
• Laser visibility

Nd:YAG and Argon Laser

Iridotomy may be performed with:

• Nd:YAG laser
• Sequential argon + Nd:YAG in thick/dark irides

depending on:

• Iris pigmentation
• Thickness
• Surgeon preference

Fellow-Eye LPI

After an acute primary angle-closure attack in one eye, the fellow eye is at substantial risk.

If the fellow eye has a narrow/occludable angle:

Prophylactic LPI is generally recommended.

LPI Complications

Potential complications include:

• Transient IOP spike
• Anterior uveitis
• Hyphema
• Corneal endothelial injury
• Dysphotopsia
• Closure of iridotomy
• Rare lens injury

Persistent Narrow Angle After LPI

A patent LPI does not guarantee that the angle becomes fully open.

Persistent narrowing may indicate:

• Plateau iris
• Large/thick lens
• PAS
• Anteriorly positioned ciliary body
• Other secondary mechanism

Laser Peripheral Iridoplasty

Argon laser peripheral iridoplasty (ALPI) contracts the peripheral iris and pulls it away from the trabecular meshwork.

It can be useful when:

• Acute closure persists
• LPI cannot initially be performed
• Plateau iris contributes
• Corneal edema makes iridotomy difficult

ALPI is usually:

Adjunctive rather than definitive for true pupillary block.

Surgical Iridectomy

Surgical peripheral iridectomy is considered when:

• Laser iridotomy cannot be performed
• Iridotomy repeatedly closes
• Significant anatomic limitations exist

Lens Extraction

Modern management increasingly recognizes the role of the lens.

Lens extraction:

• Deepens the anterior chamber
• Widens the angle
• Reduces iridolenticular contact
• Removes an important component of pupillary block

Cataract Extraction

Cataract extraction is especially appropriate when:

• Visually significant cataract is present
• Lens crowding is prominent
• Angle remains narrow after LPI
• IOP remains difficult to control
• Recurrent closure occurs

Clear Lens Extraction

In selected patients with established PAC/PACG, clear lens extraction may be considered even without visually significant cataract.

The EAGLE trial supported early lens extraction in selected patients aged ≥50 with:

• Primary angle closure with substantially elevated IOP
• Or PACG

It should not be interpreted as recommending clear-lens extraction for every PACS patient.

Goniosynechialysis

In selected eyes with relatively recent PAS, cataract extraction may be combined with:

Goniosynechialysis

to mechanically strip PAS from the trabecular meshwork.

Benefit depends on:

• Duration of PAS
• Extent of closure
• Residual trabecular function

Persistent Glaucoma After LPI

If IOP remains elevated after the pupillary-block component has been relieved, treat according to the remaining mechanism.

Options include:

• Topical medications
• Lens extraction
• Goniosynechialysis in selected cases
• Trabeculectomy
• Glaucoma drainage device
• Other glaucoma surgery

Chronic Angle-Closure Glaucoma

Patients may require a relatively low target IOP because of:

• Existing optic nerve damage
• Extensive PAS
• Reduced trabecular outflow

LPI alone may not adequately control established PACG.

Family Screening

First-degree relatives have increased risk of:

• Narrow angles
• PAC/PACG

They should have comprehensive eye examination including:

Gonioscopy when appropriate.

Follow-Up

After an acute attack or LPI, follow-up should assess:

• IOP
• Iridotomy patency
• Gonioscopy
• PAS
• Angle width
• Optic nerve
• OCT
• Visual fields

Serial Gonioscopy

Even after successful LPI:

The angle can continue to narrow over time.

Reasons include:

• Lens growth
• Plateau iris
• Progressive PAS

Therefore serial gonioscopy remains important.

Prognosis

Prognosis depends on:

• Duration of acute IOP elevation
• Peak IOP
• Extent of PAS
• Preexisting optic nerve damage
• Speed of treatment
• Residual angle function

An acute attack treated rapidly can recover excellent vision.

Prolonged untreated attacks may produce:

• Optic nerve injury
• Iris atrophy
• Corneal endothelial damage
• Lens changes
• Permanent glaucoma

Complications

Potential complications include:

• Glaucomatous optic neuropathy
• Permanent visual field loss
• PAS
• Chronic angle closure
• Optic atrophy
• Corneal endothelial damage
• Iris sphincter atrophy
• Glaukomflecken
• Central retinal vascular occlusion in severe cases

Ophthalmology Pearls

• Pupillary block is the most common mechanism of primary angle closure.
• The sequence is resistance to aqueous flow through the pupil → posterior chamber pressure rises → iris bombe → iridotrabecular contact → IOP elevation.
• Acute primary angle closure classically causes pain, red eye, blurred vision/halos, headache, nausea, corneal edema, high IOP, and a mid-dilated poorly reactive pupil.
• Indentation gonioscopy is essential for distinguishing reversible appositional closure from permanent PAS.
• Laser peripheral iridotomy is definitive treatment for the pupillary-block component because it equalizes anterior and posterior chamber pressure.
• During an acute attack, first lower IOP with aqueous suppressants ± acetazolamide ± hyperosmotic therapy, control inflammation, then perform LPI when feasible.
• Pilocarpine is often ineffective at extremely high IOP because of iris sphincter ischemia; use it after pressure begins to fall.
• A patent LPI does not guarantee a permanently open angle; persistent narrowing suggests plateau iris, lens crowding, PAS, or another mechanism.
• ALPI is a useful adjunct, especially when LPI cannot initially be performed or plateau iris contributes.
• The fellow eye after an acute primary angle-closure attack is high risk; if occludable, prophylactic LPI is generally recommended.
• Lens extraction increasingly plays an important role because it deepens the chamber and widens the angle.
• The EAGLE trial supports clear-lens extraction in selected established PAC/PACG patients, but not routine lens extraction for every asymptomatic PACS eye.
• Topiramate-induced angle closure is not pupillary block; it results from ciliochoroidal effusion, so LPI is generally ineffective.
• Even after successful LPI, continue serial gonioscopy, IOP monitoring, optic nerve/OCT assessment, and visual fields because PAS and chronic angle closure can still progress.

Ophthalmology – Congenital Ptosis

Basics

Description

Congenital ptosis is drooping of the upper eyelid that is present at birth or develops within the first year of life.

The most common form is:

Simple congenital myogenic ptosis due to levator palpebrae superioris dysgenesis

It may be:

• Unilateral
• Bilateral
• Mild to complete
• Isolated or syndromic

The major clinical concern is not cosmetic appearance but preservation of visual development by preventing:

• Amblyopia
• Significant astigmatism
• Anisometropia
• Strabismus
• Visual-axis obstruction
• Persistent abnormal head posture

Pathophysiology

In simple congenital ptosis, the levator muscle is developmentally abnormal.

Normal skeletal muscle fibers are variably replaced by:

• Fibrous tissue
• Adipose tissue

This produces:

• Reduced levator contractility
• Reduced relaxation in downgaze

The result is the classic combination of:

Ptosis in primary gaze + lid lag in downgaze

Epidemiology

Congenital ptosis is uncommon, but exact prevalence varies among populations.

Most cases are:

• Sporadic
• Idiopathic

Familial cases occur.

Genetics

The genetics of isolated congenital ptosis are heterogeneous.

Some familial forms demonstrate:

• Autosomal dominant inheritance
• X-linked inheritance
• Other chromosomal associations

Routine genetic testing is not required for isolated simple congenital ptosis.

Genetic evaluation is more useful when:

• Ptosis is bilateral
• Other congenital anomalies are present
• There is a strong family history
• A defined syndrome is suspected

Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome

BPES is an important syndromic cause of congenital ptosis.

It is associated with pathogenic variants in:

FOXL2

and usually follows an:

Autosomal dominant

inheritance pattern.

BPES Features

The classic findings are:

• Bilateral ptosis
• Blepharophimosis
• Epicanthus inversus
• Telecanthus

Some affected females also develop:

Primary ovarian insufficiency

depending on the BPES subtype.

Other Syndromic Associations

Congenital ptosis may occur with:

• Congenital fibrosis of the extraocular muscles
• Craniofacial syndromes
• Myotonic disorders
• Mitochondrial disease
• Chromosomal syndromes

Systemic evaluation is appropriate when other developmental abnormalities are present.

Clinical Presentation

The eyelid position may range from:

• Subtle asymmetry
• Partial pupillary coverage
• Complete visual-axis obstruction

Parents may notice:

• Drooping eyelid
• Chin-up posture
• Brow elevation
• Forehead wrinkling
• Eye closure asymmetry
• Strabismus

Amblyopia

Amblyopia is one of the most important complications.

It may result from:

• Visual-axis occlusion
• Induced astigmatism
• Anisometropia
• Associated strabismus

An important point:

Refractive error and strabismus are common causes of amblyopia in congenital ptosis, even when the pupil is not completely covered.

Refractive Error

Congenital ptosis may be associated with:

• Astigmatism
• Anisometropia
• Myopia
• Hyperopia

The pressure and altered contour of a ptotic lid may contribute to:

Corneal astigmatism

Therefore all children require:

Cycloplegic refraction

Abnormal Head Posture

Children with bilateral severe ptosis may compensate with:

Chin elevation

This allows them to see beneath the drooping eyelids.

Persistent chin-up posture is itself an indication to consider surgery.

Frontalis Recruitment

Children often compensate by:

• Elevating the eyebrows
• Contracting the frontalis muscle

This may partially mask the severity of ptosis.

The brow should therefore be stabilized during formal measurement.

History

Ask about:

• Present since birth?
• Stable or progressive?
• Unilateral or bilateral?
• Does it fluctuate?
• Worse when tired?
• Jaw movement change the eyelid?
• Abnormal head posture?
• Sleep with the eye partly open?
• Family history?
• Birth trauma?
• Other congenital abnormalities?

Old photographs are useful for documenting:

• Chronicity
• Symmetry
• Head posture
• Variability

Fluctuating Ptosis

True simple congenital ptosis is generally:

Stable rather than fluctuating

Marked variability should raise suspicion for:

• Myasthenia gravis
• Intermittent neurogenic disease
• Mechanical factors

Examination

A complete pediatric ophthalmic examination should assess:

• Visual acuity
• Cycloplegic refraction
• Ocular alignment
• Ocular motility
• Pupils
• Eyelid measurements
• Cornea
• Anterior segment
• Fundus

Margin Reflex Distance 1

MRD1 is the distance from the corneal light reflex to the upper eyelid margin in primary gaze.

It helps quantify:

• Ptosis severity
• Symmetry

A normal MRD1 is generally approximately:

4–5 mm

in adults, though pediatric interpretation should consider age and cooperation.

Palpebral Fissure Height

Measure the vertical distance between:

• Upper lid margin
• Lower lid margin

in primary gaze.

Compare both eyes.

Levator Function

This is the most important surgical measurement.

To measure:

1. Stabilize the brow to eliminate frontalis action.
2. Ask the patient to look from maximum downgaze to maximum upgaze.
3. Measure upper-lid excursion.

Approximate interpretation:

• Good: ≥12 mm
• Fair: 5–11 mm
• Poor: ≤4 mm

Congenital Ptosis Examination Pattern

Classic simple congenital ptosis shows:

• Poor levator function
• Weak or absent lid crease
• Lid lag in downgaze
• Possible lagophthalmos
• Frontalis overaction
• Chin-up posture in severe bilateral cases

Lid Crease

The upper eyelid crease is often:

• Weak
• Poorly formed
• Absent

because the abnormal levator has reduced attachment and function.

This contrasts with aponeurotic ptosis, which often has:

Good levator function with a high lid crease.

Lid Lag in Downgaze

This is a classic congenital ptosis feature.

Because the dysgenic levator does not relax normally, the affected eyelid remains relatively elevated in downgaze.

Thus the ptotic lid may appear:

Higher than expected in downgaze

compared with the normal side.

Bell Phenomenon

Always assess:

Bell phenomenon

before ptosis surgery.

Poor Bell phenomenon increases the risk of:

• Exposure keratopathy
• Corneal ulceration

after postoperative eyelid elevation.

Lagophthalmos

Assess:

• Voluntary closure
• Forced closure
• Sleep-related lagophthalmos when history suggests it

Children with congenital ptosis may already have incomplete closure, and surgery can worsen it.

Corneal Examination

Look for:

• Exposure
• Punctate epithelial erosions
• Scarring
• Reduced tear-film protection

especially when:

• Bell phenomenon is poor
• Lagophthalmos is present

Pupillary Examination

Pupils are essential in distinguishing congenital ptosis from neurogenic causes.

Miosis

Consider:

Horner syndrome

Mydriasis

Consider:

CN III palsy

especially if accompanied by ophthalmoplegia.

Ocular Motility

Assess all ductions and versions.

Motility abnormalities suggest diagnoses other than isolated levator dysgenesis.

Important possibilities include:

• CN III palsy
• Monocular elevation deficiency
• Congenital fibrosis of extraocular muscles
• Marcus Gunn jaw-winking
• Other congenital cranial dysinnervation disorders

Monocular Elevation Deficiency

The older term:

Double elevator palsy

is now more often termed:

Monocular elevation deficiency

The affected eye has limited elevation in:

• Abduction
• Adduction

and may appear ptotic because of:

• True ptosis
• Hypotropia-related pseudoptosis
• Both

Marcus Gunn Jaw-Winking Syndrome

Marcus Gunn jaw-winking is a congenital cranial dysinnervation disorder characterized by:

Elevation or retraction of the ptotic upper lid during jaw movement

Triggers may include:

• Sucking
• Chewing
• Opening the mouth
• Moving the jaw laterally

Marcus Gunn Mechanism

It results from aberrant innervation between:

• Trigeminal motor pathways
• Levator palpebrae superioris

It is usually:

• Unilateral
• Associated with congenital ptosis

Examination for Jaw-Winking

Observe the eyelid while the child:

• Sucks from a bottle
• Chews
• Opens the mouth
• Moves the jaw side to side

This is easily missed if not specifically tested.

Treatment of Jaw-Winking

Mild jaw-winking may simply be observed.

Significant socially or functionally troublesome synkinesis may require:

• Levator weakening/excision
• Frontalis suspension

Surgical strategy is individualized according to:

• Degree of jaw wink
• Ptosis severity
• Symmetry

Horner Syndrome

Congenital Horner syndrome may produce:

• Mild ptosis
• Miosis
• Lower-lid “reverse ptosis”
• Iris heterochromia

The affected iris may appear:

Lighter

when sympathetic disruption occurs early in life.

Congenital Horner Workup

Congenital Horner syndrome requires evaluation based on:

• Timing
• Birth trauma
• Neurologic examination
• Acquired vs clearly congenital onset

If the cause is uncertain, investigation for lesions along the sympathetic pathway may be needed.

Third Nerve Palsy

Congenital or acquired CN III dysfunction may cause:

• Ptosis
• Ophthalmoplegia
• Exotropia/hypotropia
• Possible pupil abnormality

A ptotic child with abnormal motility should not automatically be diagnosed with simple congenital ptosis.

Congenital Fibrosis of the Extraocular Muscles

CFEOM is a congenital cranial dysinnervation disorder characterized by:

• Restrictive ophthalmoplegia
• Abnormal eye position
• Ptosis
• Compensatory head posture

Genetic causes include several genes affecting cranial motor neuron development.

Myasthenia Gravis

Rarely, childhood myasthenia may mimic congenital ptosis.

Features favoring myasthenia include:

• Fluctuating ptosis
• Fatigability
• Variable diplopia
• Orbicularis weakness
• Normal pupils

Testing may include:

• AChR antibodies
• Ice-pack test
• Electrophysiology

Mechanical Ptosis

Always evert and inspect the lid when an atypical mass is suspected.

Potential causes include:

• Dermoid
• Neurofibroma
• Hemangioma
• Chalazion
• Other eyelid/orbital tumors

Imaging may be required if:

• Mass effect
• Proptosis
• Globe displacement

is present.

Pseudoptosis

Apparent congenital ptosis may result from:

• Microphthalmos
• Enophthalmos
• Hypotropia
• Contralateral lid retraction
• Brow asymmetry

These should be distinguished from true levator dysfunction.

Diagnostic Testing

Simple congenital ptosis usually requires:

No laboratory testing or imaging

The diagnosis is clinical.

When Imaging Is Indicated

Consider MRI or CT when there is:

• Abnormal ocular motility
• CN III palsy
• Suspected Horner syndrome
• Orbital mass
• Proptosis
• Rapid progression
• Neurologic abnormalities
• Atypical presentation

MRI is generally preferred when evaluating:

• Brain
• Cranial nerves
• Soft-tissue orbital pathology

Genetic Testing

Consider genetic evaluation when there is suspicion for:

• BPES
• CFEOM
• Syndromic craniofacial disease
• Multiple affected family members

Differential Diagnosis

Important differentials include:

• Simple congenital myogenic ptosis
• Marcus Gunn jaw-winking syndrome
• Horner syndrome
• CN III palsy
• Monocular elevation deficiency
• CFEOM
• Mechanical ptosis
• Birth-trauma-related ptosis
• Myasthenia gravis
• CPEO
• Myotonic dystrophy
• Microphthalmos
• Enophthalmos
• Hypotropia-related pseudoptosis
• BPES

Treatment Principles

The priorities are:

1. Prevent amblyopia
2. Correct refractive error
3. Treat strabismus when indicated
4. Correct significant abnormal head posture
5. Improve eyelid position and symmetry

Cosmesis is important but comes after preservation of visual development.

Refractive Correction

Treat:

• Astigmatism
• Anisometropia
• Hyperopia
• Myopia

with appropriate spectacles or contact lenses.

Cycloplegic refraction should be repeated periodically throughout childhood.

Amblyopia Treatment

Treatment may include:

• Spectacle correction
• Patching
• Atropine penalization in selected children

Amblyopia therapy should begin promptly when indicated and should not be delayed solely until after ptosis surgery.

Observation

Observation is appropriate for mild congenital ptosis when there is:

• Clear visual axis
• No amblyopia
• No significant refractive error
• No strabismus-related concern
• No abnormal head posture

These children still require:

Long-term visual surveillance.

Indications for Early Surgery

Early surgery is indicated when there is:

• Visual-axis obstruction
• Amblyopia or high risk of amblyopia
• Significant induced astigmatism
• Persistent chin-up posture
• Severe bilateral ptosis affecting visual development

In these circumstances:

Do not delay surgery for cosmetic-age considerations.

Timing When Vision Is Not Threatened

If vision develops normally and there is no significant head posture, surgery can often be deferred until approximately:

3–5 years of age

This allows:

• More reliable measurements
• Better tissue size
• Improved postoperative assessment

Timing should be individualized.

Surgical Choice

The operation is determined primarily by:

Levator function

Poor Levator Function

When levator function is approximately:

≤4 mm

the preferred procedure is generally:

Frontalis suspension / frontalis sling

Frontalis Sling

The eyelid is connected to the frontalis muscle so that:

Brow elevation raises the eyelid

This is especially useful for:

• Severe simple congenital ptosis
• Poor levator function
• Selected neuromuscular disorders

Sling Materials

Options include:

• Autologous fascia lata
• Silicone rod
• Other synthetic materials

Autologous fascia lata is durable but may be impractical in very young children because insufficient fascia is available.

Silicone is useful because it is:

• Adjustable
• Reversible
• Commonly used in younger children

Fair or Good Levator Function

If levator function is adequate, options include:

• Levator resection
• Levator advancement

The amount of resection depends on:

• Ptosis severity
• Levator function
• Desired eyelid height

Müller Muscle Procedures

Posterior Müller muscle–conjunctival procedures are less commonly the primary operation for classic severe congenital myogenic ptosis because:

• Levator function is often abnormal

They may be useful in carefully selected mild cases with:

• Good levator function
• Good phenylephrine response

Surgical Goals

Goals are:

• Clear visual axis
• Appropriate lid height
• Good contour
• Acceptable symmetry
• Preservation of corneal protection

Perfect symmetry in:

• Primary gaze
• Upgaze
• Downgaze

is often impossible because the dysgenic levator does not behave normally.

Postoperative Lagophthalmos

Some degree of lagophthalmos is common after congenital ptosis surgery.

This is particularly expected after:

• Frontalis sling
• Large levator resection

The key is whether the cornea remains:

Adequately protected.

Postoperative Lubrication

Management may include:

• Preservative-free tears
• Lubricating ointment
• Nighttime ointment
• Temporary taping in selected cases

especially when lagophthalmos is significant.

Exposure Keratopathy

Risk is greater with:

• Poor Bell phenomenon
• Reduced corneal sensation
• Aggressive correction
• Preexisting dry eye
• Severe bilateral surgery

Monitor carefully for:

• Punctate epitheliopathy
• Persistent epithelial defect
• Corneal ulceration

Hering’s Law

In asymmetric bilateral ptosis, increased central levator drive may elevate the less ptotic eyelid.

After correcting one eyelid:

The fellow eyelid may fall

revealing previously masked bilateral ptosis.

This should be assessed before surgery.

Strabismus

Strabismus is relatively common in congenital ptosis.

Management depends on:

• Visual axis
• Head posture
• Ocular alignment
• Type of motility disorder

In some patients:

Strabismus surgery is performed before ptosis surgery

because changing ocular alignment can alter apparent eyelid position.

Follow-Up

Children require regular follow-up throughout visual development.

Monitor:

• Visual acuity
• Cycloplegic refraction
• Amblyopia
• Ocular alignment
• MRD1
• Levator function
• Chin-up posture
• Corneal exposure
• Recurrence

Frequency

Follow-up is individualized.

Infants and young children at amblyopia risk require:

Closer and more frequent surveillance

than older children with stable mild ptosis.

Recurrence

Ptosis may recur because of:

• Growth
• Sling stretching
• Material degradation
• Progressive tissue changes

Repeat surgery may occasionally be necessary.

Surgical Complications

Potential complications include:

• Undercorrection
• Overcorrection
• Eyelid asymmetry
• Abnormal contour
• Lagophthalmos
• Exposure keratopathy
• Infection
• Granuloma
• Sling extrusion
• Recurrence

Frontalis Sling Infection

Synthetic sling material can rarely cause:

• Infection
• Granuloma
• Extrusion

Management may require:

• Antibiotics
• Drainage
• Partial or complete sling removal

Prognosis

With appropriate surveillance and treatment:

Visual prognosis is generally excellent.

The most important preventable cause of poor vision is:

Amblyopia

rather than the lid abnormality itself.

Ophthalmology Pearls

• Simple congenital ptosis is usually caused by levator dysgenesis with fibrofatty replacement of normal muscle.
• The classic examination is poor levator function + weak lid crease + lid lag in downgaze.
• The major threat is amblyopia, which can arise from visual-axis obstruction, astigmatism, anisometropia, or associated strabismus.
• Every child with congenital ptosis requires cycloplegic refraction and amblyopia surveillance, even if the pupil is not completely covered.
• A chin-up posture suggests functionally significant ptosis and may itself justify surgery.
• Always examine pupils and ocular motility to exclude Horner syndrome, CN III palsy, and congenital cranial dysinnervation disorders.
• Marcus Gunn jaw-winking causes lid elevation with jaw movement and should be specifically tested during chewing or sucking.
• The historical term double elevator palsy is now more commonly called monocular elevation deficiency.
• BPES is associated with FOXL2 and features bilateral ptosis, blepharophimosis, epicanthus inversus, and telecanthus.
• Simple congenital ptosis usually requires no laboratory testing or neuroimaging unless neurologic, motility, orbital, or syndromic findings are present.
• Surgery should be performed early if the visual axis is obstructed, amblyopia risk is high, or a significant chin-up posture is present.
• When visual development is not threatened, surgery can often be deferred until approximately 3–5 years of age.
• Poor levator function (≈4 mm or less) → frontalis sling is the classic surgical principle.
• Fair/good levator function → levator resection or advancement is usually preferred.
• Check Bell phenomenon and corneal exposure risk before surgery.
• Some postoperative lagophthalmos is expected, particularly after frontalis suspension; the critical issue is maintaining corneal protection.
• Congenital ptosis requires follow-up throughout childhood because refractive error, amblyopia, strabismus, and recurrence can evolve over time.

Ophthalmology – Ptosis

Basics

Description

Ptosis (blepharoptosis) is abnormal drooping of the upper eyelid caused by dysfunction of the eyelid-elevating apparatus.

It may be:

• Congenital
• Acquired
• Unilateral or bilateral

Ptosis can cause:

• Superior visual field loss
• Reduced central vision if severe
• Astigmatism
• Abnormal head posture
• Amblyopia in children

The key clinical task is to determine:

Is the ptosis aponeurotic, myogenic, neurogenic, mechanical, traumatic, or pseudoptosis?

⸻

Eyelid Elevators

The upper eyelid is elevated primarily by:

Levator Palpebrae Superioris

• Innervated by CN III
• Provides most upper eyelid elevation

Müller Muscle

• Sympathetically innervated
• Contributes approximately 1–2 mm of elevation

Frontalis Muscle

• Innervated by CN VII
• Can compensate by elevating the eyebrow

⸻

Classification

The major categories are:

• Aponeurotic
• Myogenic
• Neurogenic
• Mechanical
• Traumatic
• Congenital developmental
• Pseudoptosis

⸻

Aponeurotic Ptosis

Aponeurotic/involutional ptosis is the most common acquired form in adults.

It results from:

• Stretching
• Thinning
• Dehiscence
• Disinsertion

of the levator aponeurosis.

⸻

Risk Factors for Aponeurotic Ptosis

Associations include:

• Aging
• Previous intraocular surgery
• Long-term contact lens wear
• Chronic eye rubbing
• Repeated eyelid manipulation
• Trauma

⸻

Typical Aponeurotic Examination

Classic findings include:

• Mild–moderate ptosis
• Good levator function
• High or absent upper lid crease
• Deep superior sulcus
• Lid lag may be absent
• Ptosis may appear more pronounced in downgaze

⸻

Congenital Ptosis

Most simple congenital ptosis results from:

Levator muscle dysgenesis

with replacement of normal muscle by:

• Fibrous tissue
• Fatty tissue

This causes both:

• Reduced elevation
• Reduced relaxation

⸻

Congenital Examination

Typical findings include:

• Ptosis present from birth or infancy
• Poor levator function
• Weak or absent eyelid crease
• Lid lag in downgaze
• Possible lagophthalmos
• Compensatory brow elevation
• Chin-up head posture

⸻

Pediatric Importance

Congenital ptosis can cause amblyopia through:

• Visual-axis occlusion
• Induced astigmatism
• Anisometropia
• Associated strabismus

Every child with ptosis requires:

• Cycloplegic refraction
• Amblyopia assessment
• Strabismus examination
• Visual-axis assessment

⸻

Timing of Congenital Ptosis Surgery

If the eyelid obstructs the visual axis or produces significant abnormal head posture:

Early surgery may be necessary to prevent amblyopia.

If there is no amblyopia risk, surgery can often be delayed until:

• Later preschool years

when measurements and postoperative cooperation are easier.

⸻

Myogenic Ptosis

Myogenic ptosis results from intrinsic dysfunction of the levator or related skeletal muscle.

Causes include:

• Myasthenia gravis
• Chronic progressive external ophthalmoplegia
• Oculopharyngeal muscular dystrophy
• Myotonic dystrophy
• Other mitochondrial or muscular disorders

⸻

Myasthenia Gravis

Myasthenia is an essential cause of:

Variable or fluctuating ptosis

Typical features include:

• Ptosis worsens with fatigue
• Improvement after rest
• Variable diplopia
• Orbicularis weakness
• Cogan lid twitch
• Enhancement of ptosis
• Pupils remain normal

⸻

Myasthenia Pearl

A pupil abnormality should make isolated ocular myasthenia:

Much less likely

because the autonomic pupil is typically spared.

⸻

Ice-Pack Test

An ice-pack test may support ocular myasthenia.

After several minutes of cooling the eyelid:

• Improvement in ptosis of approximately 2 mm or more

supports the diagnosis.

It is:

• Simple
• Noninvasive
• Particularly useful in ptosis-predominant disease

⸻

Laboratory Testing for Myasthenia

Consider:

• AChR antibodies
• MuSK antibodies in selected seronegative generalized cases
• Other antibody testing depending on clinical context

Electrophysiology may include:

• Repetitive nerve stimulation
• Single-fiber EMG, which is highly sensitive

⸻

Important Modern Correction – Edrophonium

The historical:

Edrophonium (Tensilon) test

is now rarely used because:

• Availability is limited
• Cardiac/cholinergic adverse effects are possible
• Safer diagnostic alternatives exist

⸻

Chronic Progressive External Ophthalmoplegia

CPEO typically causes:

• Slowly progressive bilateral ptosis
• Symmetric ophthalmoplegia
• Little diplopia despite marked motility restriction

because progression is gradual and symmetric.

It is often associated with:

Mitochondrial disease.

⸻

Oculopharyngeal Muscular Dystrophy

Typically presents in later adulthood with:

• Bilateral ptosis
• Dysphagia

Family history may be present.

⸻

Myotonic Dystrophy

May produce:

• Bilateral ptosis
• Orbicularis weakness
• Ophthalmoplegia
• Christmas-tree cataract
• Systemic myotonia

⸻

Neurogenic Ptosis

Major causes include:

• Third cranial nerve palsy
• Horner syndrome
• Rare central neurologic disease

These are especially important in acute ptosis.

⸻

Third Nerve Palsy

CN III innervates:

• Levator palpebrae
• Superior rectus
• Inferior rectus
• Medial rectus
• Inferior oblique
• Parasympathetic pupillary fibers

⸻

Classic Third Nerve Palsy

Findings may include:

• Marked or complete ptosis
• Eye positioned “down and out”
• Adduction deficit
• Elevation deficit
• Depression deficit
• Diplopia
• Possible dilated pupil

⸻

Pupil-Involving Third Nerve Palsy

An acute third nerve palsy with:

• Mydriasis
• Pain
• Partial ophthalmoplegia

must raise concern for:

Posterior communicating artery aneurysm

and requires urgent vascular imaging.

⸻

Modern Imaging Principle for Third Nerve Palsy

Because aneurysms can occasionally present atypically:

Acute acquired third nerve palsy generally warrants urgent neurovascular imaging, particularly if:

• Pupil is involved
• Palsy is partial
• Severe headache/pain is present
• Patient is young
• Pattern is atypical

Preferred studies include:

• CTA
• MRA

with catheter angiography reserved for selected cases.

⸻

Horner Syndrome

Horner syndrome results from interruption of the sympathetic pathway.

Classic findings include:

• Mild upper eyelid ptosis
• Miosis
• Lower eyelid elevation (“reverse ptosis”)
• Apparent enophthalmos
• Possible facial anhidrosis depending on lesion location

⸻

Horner Ptosis

Because Müller muscle contributes only a small amount of lid elevation, Horner ptosis is usually:

Mild

rather than complete.

⸻

Congenital Horner Syndrome

Congenital or long-standing early childhood Horner syndrome may produce:

Iris heterochromia

with the affected iris appearing lighter.

⸻

Painful Horner Syndrome

Acute Horner syndrome associated with:

• Ipsilateral neck pain
• Facial pain
• Headache

should be considered:

Internal carotid artery dissection until proven otherwise.

Urgent:

• CTA head/neck
• MRA head/neck

is indicated.

⸻

Pharmacologic Testing for Horner Syndrome

Modern confirmation usually uses:

Apraclonidine

because denervation supersensitivity produces:

• Dilation of the affected pupil
• Improvement of mild ptosis

The anisocoria may reverse after testing.

⸻

Important Modern Correction – Cocaine/Hydroxyamphetamine

Older testing used:

• Cocaine
• Hydroxyamphetamine

These are now much less commonly used because:

• Availability is limited
• Apraclonidine is simpler
• Localization is increasingly performed with imaging rather than pharmacologic hydroxyamphetamine testing

Use caution with apraclonidine in:

Very young infants

because systemic CNS and cardiovascular adverse effects can occur.

⸻

Marcus Gunn Jaw-Winking Syndrome

This congenital synkinesis causes:

Upper eyelid elevation with jaw movement

such as:

• Chewing
• Sucking
• Moving jaw to opposite side

It results from aberrant innervation between:

• Trigeminal motor pathways
• Levator palpebrae

It is often associated with congenital ptosis.

⸻

Blepharophimosis Syndrome

The classic BPES phenotype includes:

• Bilateral ptosis
• Blepharophimosis
• Epicanthus inversus
• Telecanthus

It is commonly associated with:

FOXL2

mutations and follows an autosomal dominant pattern.

Some forms are associated with:

• Premature ovarian insufficiency

⸻

Mechanical Ptosis

Mechanical ptosis occurs when excess weight or structural abnormality pulls the lid downward.

Causes include:

• Eyelid tumor
• Chalazion
• Eyelid edema
• Amyloid deposition
• Neurofibroma
• Scar
• Severe dermatochalasis
• Giant papillary conjunctivitis

⸻

Traumatic Ptosis

Trauma can damage:

• Levator muscle
• Levator aponeurosis
• CN III
• Sympathetic fibers

Mechanism may include:

• Laceration
• Contusion
• Orbital injury

⸻

Post-Traumatic Observation

Some blunt-trauma ptosis improves spontaneously as:

• Edema resolves
• Nerve function recovers
• Muscle injury heals

Definitive surgery is often delayed when reasonable, but:

A fixed six-month waiting period is not required in every case.

Repair may be earlier when there is:

• Clear levator transection
• Significant laceration
• Visual-axis obstruction
• Little expectation of spontaneous recovery

⸻

Reactive Ptosis

Painful ocular disease may produce temporary ptosis from:

• Reflex orbicularis activation
• Inflammation
• Swelling

Examples include:

• Corneal abrasion
• Uveitis
• Orbital inflammation

Treating the underlying disorder usually improves the lid position.

⸻

Pseudoptosis

Not all apparent ptosis represents true upper eyelid elevator dysfunction.

Causes of pseudoptosis include:

• Dermatochalasis
• Brow ptosis
• Contralateral upper lid retraction
• Enophthalmos
• Microphthalmos
• Phthisis bulbi
• Hypotropia
• Small or recessed globe

⸻

History

Important questions include:

• Congenital or acquired?
• Acute or gradual?
• Constant or fluctuating?
• Worse late in day?
• Associated diplopia?
• Pupil change?
• Headache or neck pain?
• Previous ocular surgery?
• Trauma?
• Contact lens wear?
• Difficulty swallowing or generalized weakness?
• Family history?

Old photographs are particularly useful for determining:

Chronicity.

⸻

Examination – Core Measurements

A formal ptosis examination should document:

• MRD1
• MRD2
• Palpebral fissure height
• Levator function
• Upper lid crease height
• Brow position
• Lagophthalmos
• Bell phenomenon

⸻

Margin Reflex Distance 1

MRD1 is the distance between:

• Central corneal light reflex
• Upper eyelid margin

in primary gaze.

Normal MRD1 is approximately:

4–5 mm

although normal values vary.

⸻

Ptosis Severity by MRD1

Approximate clinical description:

• Mild: ~2 mm droop
• Moderate: ~3 mm
• Severe: ≥4 mm or pupil covered

The actual surgical decision depends on:

• Levator function
• Etiology
• Visual function

not simply droop magnitude.

⸻

Levator Function

Measured by:

• Stabilizing the brow to eliminate frontalis action
• Measuring upper lid excursion from downgaze to upgaze

Approximate interpretation:

• Good: ≥12 mm
• Fair: ~5–11 mm
• Poor: ≤4 mm

These categories guide surgical choice.

⸻

Lid Crease

A:

High lid crease + good levator function

strongly suggests:

Aponeurotic ptosis.

A weak or absent crease with poor levator function favors:

Congenital myogenic ptosis.

⸻

Brow Examination

Patients may compensate for ptosis by:

• Elevating eyebrows
• Wrinkling forehead

The brow should therefore be manually relaxed when evaluating true eyelid position.

⸻

Pupils

Pupil examination is mandatory in:

Any new ptosis.

Look for:

• Miosis → Horner syndrome
• Mydriasis → CN III palsy
• Anisocoria pattern in light vs dark

⸻

Ocular Motility

Assess:

• Ductions
• Versions
• Alignment
• Diplopia

Ptosis associated with ophthalmoplegia strongly suggests:

• CN III palsy
• Myasthenia
• CPEO
• Orbital disease

rather than simple aponeurotic ptosis.

⸻

Bell Phenomenon

Assess Bell phenomenon before surgery.

Poor Bell phenomenon increases the risk of:

Postoperative exposure keratopathy

especially after aggressive elevation.

⸻

Corneal Sensation and Ocular Surface

Assess:

• Tear film
• Corneal sensation
• Exposure
• Dry eye
• Lagophthalmos

because ptosis correction may worsen:

• Exposure keratopathy
• Dry eye symptoms

⸻

Upper Lid Eversion

Evert the upper lid when mechanical disease is possible.

Look for:

• Foreign body
• Giant papillary conjunctivitis
• Mass
• Scar

⸻

Hering’s Law

Elevation of the upper eyelids is bilaterally linked through central innervation.

In unilateral ptosis, the brain may increase levator drive to both eyes.

After lifting the ptotic lid, the fellow lid may:

Drop

revealing previously masked bilateral ptosis.

This is the:

Hering phenomenon

and is important for surgical planning.

⸻

Phenylephrine Test

Topical phenylephrine stimulates Müller muscle.

Improvement of ptosis can help identify patients who may respond to:

Müller muscle–conjunctival resection (MMCR)

It also helps estimate postoperative eyelid position in selected cases.

⸻

Visual Field Testing

Functional visual fields may document:

• Superior field loss

from ptosis.

Testing may be performed:

• With eyelid in natural position
• With lid taped/elevated

to demonstrate functional improvement.

⸻

Clinical Photography

Standardized external photographs are useful for:

• Baseline documentation
• Surgical planning
• Insurance/functional documentation
• Postoperative comparison

⸻

Imaging

Imaging is not required for typical chronic aponeurotic or congenital ptosis.

Obtain imaging when the history or examination suggests:

• Orbital mass
• Neurologic lesion
• CN III palsy
• Horner syndrome
• Trauma

⸻

Orbital Mass

Consider:

• CT orbit
• MRI orbit

when there is:

• Proptosis
• Globe displacement
• Palpable mass
• Progressive unilateral mechanical ptosis
• Motility restriction

⸻

Differential Diagnosis

Important differential diagnoses include:

• Dermatochalasis
• Brow ptosis
• Contralateral lid retraction
• Enophthalmos
• Hypotropia
• Microphthalmos
• Phthisis bulbi
• Eyelid edema

⸻

Treatment Principles

Treatment depends on:

• Etiology
• Severity
• Visual impairment
• Levator function
• Ocular surface status
• Patient goals

Before surgery:

Treat the underlying neurologic, muscular, inflammatory, or mechanical cause whenever possible.

⸻

Observation

Observation is appropriate for:

• Mild stable ptosis
• No visual field impairment
• No amblyopia risk
• Acceptable cosmesis

⸻

Medical Treatment – Myasthenia

Treatment may include:

• Pyridostigmine
• Corticosteroids
• Steroid-sparing immunosuppressants
• IVIG or plasma exchange in selected severe disease
• Targeted biologic therapy in appropriate generalized disease

Ptosis surgery is usually avoided until ocular myasthenia is:

Stable and medically optimized.

⸻

Acquired Ptosis Medication

In selected adults with acquired ptosis, topical:

Oxymetazoline 0.1%

can temporarily elevate the upper eyelid by stimulating Müller muscle.

It is most useful in:

• Mild acquired ptosis

It does not correct:

• Severe levator dysfunction
• Mechanical ptosis
• Major neurologic disease

⸻

Eyelid Crutch

A spectacle-mounted eyelid crutch may be considered in patients who:

• Are poor surgical candidates
• Have neuromuscular disease
• Need temporary mechanical elevation

Potential problems include:

• Dry eye
• Exposure
• Discomfort

⸻

Surgical Treatment

Main surgical approaches include:

• External levator advancement/resection
• Müller muscle–conjunctival resection
• Frontalis suspension

Choice depends primarily on:

• Etiology
• Levator function
• Degree of ptosis

⸻

External Levator Advancement

Best suited for:

Aponeurotic ptosis with good levator function

The levator aponeurosis is:

• Reattached
• Advanced

onto the tarsal plate.

This is a standard procedure for involutional ptosis.

⸻

Levator Resection

Levator resection may be used in:

• Congenital ptosis
• Fair to good levator function

The amount of resection is adjusted according to:

• Ptosis severity
• Levator function

⸻

Müller Muscle–Conjunctival Resection

MMCR is particularly useful for:

• Mild–moderate ptosis
• Good levator function
• Good response to phenylephrine

Advantages include:

• Posterior approach
• No external skin incision
• Predictable contour in selected patients

⸻

Fasanella-Servat Procedure

Historical posterior lamellar shortening procedures remain available but are:

Less commonly emphasized than modern MMCR techniques.

⸻

Frontalis Sling

Frontalis suspension is usually used when levator function is:

Poor

especially in:

• Severe congenital ptosis
• Selected neuromuscular disorders

The eyelid is linked to the frontalis muscle so brow elevation raises the lid.

⸻

Frontalis Sling Materials

Options include:

• Autologous fascia lata
• Silicone rod
• Other synthetic materials

Selection depends on:

• Age
• Etiology
• Surgeon preference

⸻

Exposure Risk After Surgery

All ptosis surgery carries a risk of:

• Lagophthalmos
• Exposure keratopathy

Risk is particularly important with:

• Poor Bell phenomenon
• Reduced corneal sensation
• Severe dry eye
• CPEO
• Aggressive frontalis sling

⸻

Postoperative Complications

Potential complications include:

• Undercorrection
• Overcorrection
• Asymmetry
• Abnormal contour
• Lagophthalmos
• Exposure keratopathy
• Dry eye
• Infection
• Hemorrhage
• Recurrence
• Need for revision

⸻

Congenital Ptosis Prognosis

Visual prognosis is good when:

• Amblyopia is prevented
• Refractive error is corrected
• Strabismus is treated
• Visual axis remains clear

Cosmetic symmetry can often be significantly improved but may not be perfect.

⸻

Acquired Aponeurotic Ptosis Prognosis

Surgical prognosis is generally:

Excellent

with appropriate patient selection.

Some patients develop:

• Recurrent aponeurotic stretching
• Contralateral ptosis
• Residual asymmetry

over time.

⸻

Emergency Ptosis Red Flags

Urgent evaluation is required for:

• Acute ptosis + dilated pupil
• Acute ptosis + ophthalmoplegia
• Painful acute Horner syndrome
• Acute ptosis with severe headache
• Ptosis with new neurologic deficits
• Rapidly progressive orbital signs
• Ptosis with generalized weakness or respiratory symptoms suggesting myasthenic crisis

⸻

Ophthalmology Pearls

• Ptosis is classified as aponeurotic, myogenic, neurogenic, mechanical, traumatic, congenital, or pseudoptosis.
• Involutional/aponeurotic ptosis is the most common acquired form and typically shows good levator function with a high lid crease.
• Simple congenital ptosis usually reflects levator dysgenesis, causing poor levator function and lid lag in downgaze.
• Children with ptosis must be evaluated for amblyopia, astigmatism, anisometropia, strabismus, and visual-axis occlusion.
• Always examine pupils and ocular motility in any acute ptosis.
• Acute CN III palsy, especially with mydriasis, pain, or partial ophthalmoplegia, requires urgent vascular imaging for aneurysm.
• Painful acute Horner syndrome should be considered carotid dissection until proven otherwise.
• Horner syndrome produces mild ptosis + miosis, while CN III palsy may produce severe ptosis with a “down-and-out” eye and possible mydriasis.
• Variable fatigable ptosis with normal pupils suggests myasthenia gravis; the ice-pack test and AChR antibody testing are useful modern investigations.
• Edrophonium/Tensilon testing is now largely historical.
• Apraclonidine is the common modern pharmacologic confirmation test for Horner syndrome, although caution is required in infants.
• Measure MRD1, levator function, lid crease, brow position, Bell phenomenon, and lagophthalmos before planning surgery.
• A high lid crease with good levator function favors aponeurotic ptosis.
• Poor levator function generally favors a frontalis sling, whereas aponeurotic ptosis with good function is usually treated with levator advancement.
• MMCR is useful for selected mild–moderate ptosis with good levator function and a favorable phenylephrine response.
• Consider Hering’s law: correcting one ptotic lid may reveal previously masked ptosis of the fellow eye.
• The major postoperative concern is exposure keratopathy, particularly in patients with poor Bell phenomenon or ocular surface disease.

Ophthalmology – Pterygium

Basics

Description

A pterygium is a benign, fibrovascular, wing-shaped growth of bulbar conjunctiva that crosses the limbus and extends onto the cornea.

It most commonly arises:

Nasally within the interpalpebral fissure

and grows toward the visual axis.

Although benign, it can impair vision through:

• Induced astigmatism
• Tear-film disturbance
• Corneal flattening/distortion
• Direct involvement of the visual axis
• Postoperative recurrence

Clinical Importance

Most pterygia are initially:

Observed

Surgery is considered when there is:

• Progressive growth toward the visual axis
• Significant induced astigmatism
• Reduced vision
• Recurrent inflammation or irritation
• Restriction of ocular motility
• Contact lens intolerance
• Significant cosmetic concern
• Suspicion for atypical or neoplastic pathology

Epidemiology

Pterygium is strongly associated with chronic environmental exposure.

It is more common in:

• Tropical and subtropical regions
• Populations living near the equator
• Outdoor workers
• Individuals with prolonged UV exposure

The classic epidemiologic association is sometimes called:

The “pterygium belt”

roughly within 30–40° latitude of the equator.

Risk Factors

Major risk factors include:

• Ultraviolet radiation
• Outdoor occupation
• Wind
• Dust
• Dry environments
• Chronic ocular surface irritation
• Increasing cumulative lifetime exposure

Additional influences may include:

• Genetic susceptibility
• Ocular surface inflammation

UV Radiation

The strongest environmental risk factor is:

Chronic UV-B exposure

UV light may induce:

• Oxidative stress
• Limbal epithelial injury
• Abnormal fibrovascular proliferation
• Matrix remodeling

Prevention

Preventive measures include:

• UV-blocking sunglasses
• Wraparound eyewear
• Wide-brimmed hat
• Protection from excessive wind and dust
• Ocular surface lubrication in dry environments

These measures may reduce:

• New lesion development
• Progression
• Postoperative recurrence risk

Pathophysiology

Pterygium is not simply a passive “degeneration.”

Modern understanding favors an active proliferative process involving:

• UV-induced limbal epithelial damage
• Altered limbal stem-cell function
• Fibroblast activation
• Extracellular matrix remodeling
• Angiogenesis
• Chronic inflammation

There may also be dysregulation of:

• Matrix metalloproteinases
• VEGF
• Transforming growth factor pathways

Histopathology

Typical findings include:

• Elastotic degeneration of conjunctival stroma
• Fibrovascular proliferation
• Abnormal collagen
• Chronic inflammatory cells
• Invasion of superficial cornea

This actinic stromal change is often termed:

Elastotic degeneration

HPV

Human papillomavirus has been detected in some pterygium specimens.

However:

HPV is not considered an established universal cause of pterygium.

Its role remains variable and population-dependent.

Clinical Anatomy

A pterygium has:

• Head – leading edge on cornea
• Neck – region crossing the limbus
• Body – fibrovascular conjunctival portion

Location

Most are:

Nasal

because the nasal interpalpebral limbus receives substantial reflected and peripheral UV exposure.

Less commonly:

• Temporal pterygium
• Double-headed nasal and temporal pterygia

A purely temporal or otherwise atypical lesion deserves closer evaluation for alternative pathology.

Symptoms

Patients may report:

• Redness
• Foreign-body sensation
• Burning
• Irritation
• Dryness
• Intermittent inflammation
• Cosmetic concern
• Blurred vision
• Distorted vision

Visual Loss

Vision may decrease because of:

• Induced astigmatism
• Irregular astigmatism
• Tear-film instability
• Corneal scarring
• Direct encroachment on the visual axis

Visual distortion can occur well before the lesion reaches the pupillary center.

Induced Astigmatism

Pterygium typically produces:

Corneal flattening along the horizontal meridian

which commonly induces:

With-the-rule astigmatism

Increasing lesion size is associated with increasing:

• Astigmatism
• Corneal irregularity

Slit-Lamp Examination

Typical appearance:

• Triangular fibrovascular tissue
• Apex directed centrally
• Body arising from bulbar conjunctiva
• Extension across the limbus onto cornea

Assess:

• Size
• Vascularity
• Thickness
• Corneal extension
• Progression
• Degree of inflammation
• Distance from visual axis

Active / Progressive Appearance

A more active pterygium may appear:

• Thick
• Fleshy
• Hyperemic
• Highly vascular

These lesions are more likely to:

• Progress
• Recur after surgery

Stocker Line

A Stocker line is a line of:

Iron deposition in the corneal epithelium just anterior to the pterygium head

It reflects chronicity and tear-film iron deposition.

It should not be interpreted as a reliable marker that the lesion is completely inactive.

Fuchs Islets

Small gray-white spots near the pterygium head may occasionally represent:

Fuchs islets

and are associated with epithelial changes near the advancing edge.

Diagnosis

Diagnosis is usually:

Clinical

based on slit-lamp appearance.

Routine laboratory testing is unnecessary.

Corneal Topography / Tomography

Topography is useful when assessing:

• Induced astigmatism
• Irregular corneal shape
• Surgical timing
• Preoperative planning

It can demonstrate:

• Horizontal flattening
• Asymmetric astigmatism
• Irregularity extending beyond visible lesion margins

Photography

Serial slit-lamp photography is useful for:

• Documenting size
• Monitoring progression
• Counseling patients

Biopsy / Histopathology

Routine biopsy is not necessary for a classic small pterygium.

However, excised tissue is often submitted for:

Histopathologic examination

especially when the lesion is:

• Atypical
• Leukoplakic
• Nodular
• Rapidly growing
• Unusually vascular
• Temporal
• Recurrent with unusual morphology

This helps exclude:

Ocular surface squamous neoplasia (OSSN).

Differential Diagnosis

Important differentials include:

• Pseudopterygium
• Pinguecula
• Ocular surface squamous neoplasia
• Conjunctival intraepithelial neoplasia
• Squamous cell carcinoma
• Limbal dermoid
• Salzmann nodular degeneration
• Peripheral corneal scar

Pterygium vs Pinguecula

Pinguecula

• Yellow-white elevated conjunctival lesion
• Located adjacent to limbus
• Does not cross onto cornea

Pterygium

• Fibrovascular growth
• Crosses the limbus
• Extends onto cornea

Pterygium vs Pseudopterygium

A pseudopterygium is conjunctival adhesion to the cornea caused by:

• Trauma
• Chemical injury
• Inflammation
• Peripheral corneal ulceration

Unlike a true pterygium:

• It can occur at any limbal location
• It is not necessarily confined to the interpalpebral zone

A probe may sometimes pass beneath portions of the pseudopterygium away from the site of adhesion:

Bowman probe test

though this maneuver is not always necessary.

Pterygium vs OSSN

Features concerning for OSSN include:

• Gelatinous or leukoplakic surface
• Feeder vessels
• Nodularity
• Rapid growth
• Atypical temporal location
• Irregular epithelial thickening

If suspicious:

Do not assume the lesion is a simple pterygium.

Consider:

• High-resolution anterior segment OCT
• Excisional/incisional biopsy
• Histopathology

Medical Treatment

Medical therapy does not remove a pterygium.

Treatment is aimed at:

Symptom control and inflammation reduction.

Lubrication

First-line symptomatic treatment includes:

• Artificial tears
• Lubricating ointment
• Preservative-free preparations when frequent use is needed

These improve:

• Irritation
• Tear-film instability
• Foreign-body sensation

Topical Steroids

A short course of mild topical corticosteroid may be considered for:

• Acute inflammatory flare
• Significant hyperemia
• Irritation

Use should be limited and monitored because of:

• IOP elevation
• Cataract
• Infection risk

Vasoconstrictors

Chronic use of topical vasoconstrictors should generally be:

Avoided

because of:

• Rebound hyperemia
• Tachyphylaxis
• Ocular surface irritation

Surgical Indications

Surgery is indicated when there is:

• Progressive growth toward visual axis
• Reduced visual acuity
• Significant induced astigmatism
• Irregular astigmatism
• Recurrent troublesome inflammation
• Restrictive motility
• Persistent symptoms despite conservative therapy
• Cosmetic concern
• Suspicion for dysplasia or malignancy

Timing of Surgery

Surgery should ideally occur:

Before major central corneal scarring or severe visual-axis involvement develops.

However, proximity to the visual axis alone is not the only criterion.

Increasing:

• Astigmatism
• Corneal distortion

may justify surgery before the lesion reaches the center.

Preferred Surgical Technique

For most primary pterygia, the preferred approach is:

Excision with conjunctival autograft

often including limbal conjunctiva.

This provides:

• Low recurrence
• Good cosmetic result
• Restoration of normal conjunctival anatomy

Conjunctival Autograft

The graft is usually obtained from:

• Superior bulbar conjunctiva

It is placed over the bare scleral defect after excision.

It may be secured with:

• Sutures
• Fibrin glue
• Autologous blood in selected techniques

Fibrin Glue

Potential advantages include:

• Shorter surgery
• Less postoperative discomfort
• Reduced suture-related inflammation

Disadvantages include:

• Cost
• Rare graft displacement
• Potential biologic product concerns depending on preparation

Bare Sclera Technique

Simple excision leaving bare sclera has a:

High recurrence rate

and is generally:

Not recommended as routine primary treatment.

Conjunctival-Limbal Autograft

Including limbal tissue may:

• Restore limbal barrier function
• Reduce recurrence

especially in:

• Young patients
• Aggressive lesions
• Recurrent pterygia

Care must be taken not to damage the donor limbus excessively.

Mitomycin C

Mitomycin C (MMC) can reduce recurrence by inhibiting fibroblast proliferation.

It may be used:

• Intraoperatively
• Occasionally postoperatively in specialized protocols

MMC Risks

MMC must be used cautiously because complications may include:

• Scleral thinning
• Scleral melt
• Delayed epithelial healing
• Corneal toxicity
• Infectious scleritis
• Secondary glaucoma
• Severe ocular surface complications

It is generally reserved for:

• High-risk primary lesions
• Recurrent pterygia
• Selected surgical cases

Amniotic Membrane Transplantation

Amniotic membrane may be used when:

• Conjunctiva must be preserved
• Defect is large
• There is significant ocular surface disease
• Prior surgery limits available conjunctiva

However:

Recurrence is generally higher with amniotic membrane alone than with conjunctival autograft for routine primary pterygium surgery.

Preserving Conjunctiva

Conjunctival preservation may be particularly important in patients who may later need:

• Trabeculectomy
• Glaucoma drainage surgery

In such patients, surgical planning should consider future glaucoma needs.

Postoperative Treatment

Typical postoperative therapy includes:

• Topical antibiotic for a short course
• Topical corticosteroid with gradual taper
• Lubrication

The exact steroid duration depends on:

• Inflammation
• Healing
• Recurrence risk
• Surgical technique

Important Modern Correction – Steroid Duration

A fixed requirement for:

Six months of postoperative topical steroid

is not standard for every patient.

Many patients are treated for:

• Several weeks
• Sometimes a few months

with tapering individualized to inflammation and recurrence risk.

Recurrence

Recurrence is the most important postoperative complication.

It usually occurs within:

The first 6–12 months

although later recurrence can occur.

Risk Factors for Recurrence

Higher recurrence risk is associated with:

• Younger age
• Fleshy/vascular pterygium
• Large lesion
• Recurrent pterygium
• Persistent postoperative inflammation
• High UV exposure
• Bare sclera technique
• Inadequate fibrovascular tissue removal

Recurrent Pterygium

Recurrent lesions may be:

• More vascular
• More fibrotic
• More adherent
• More difficult to remove

They may cause:

• Restrictive strabismus
• Significant corneal scarring
• Symblepharon

Management often requires:

• Extensive scar dissection
• Conjunctival-limbal autograft
• MMC
• Amniotic membrane in selected cases

Postoperative Complications

Potential complications include:

• Recurrence
• Graft edema
• Graft displacement
• Granuloma
• Dellen formation
• Infection
• Diplopia
• Scleral thinning
• Corneal scar
• Persistent epithelial defect
• Rare scleral melt

Dellen

A corneal dellen is localized peripheral corneal thinning caused by:

• Tear-film instability
• Adjacent elevation

It may occur near:

• Pterygium
• Postoperative graft elevation

Treatment includes:

• Aggressive lubrication
• Reduction of adjacent inflammation/elevation

Follow-Up

Small stable lesions can generally be followed:

• Periodically
• Often annually

Earlier review is appropriate if there is:

• Documented progression
• Increasing astigmatism
• Increasing symptoms
• Suspicious morphology

Postoperative Follow-Up

Monitor for:

• Epithelial healing
• Graft position
• Infection
• IOP elevation from steroids
• Recurrence

Long-term UV protection should be encouraged.

Prognosis

Prognosis is generally:

Excellent

when lesions are small and managed appropriately.

After surgery, visual improvement may result from:

• Reduced astigmatism
• Improved corneal regularity

However, longstanding central lesions may leave:

• Persistent corneal scar
• Residual irregular astigmatism

Ophthalmology Pearls

• Pterygium is a benign fibrovascular conjunctival growth that crosses the limbus onto the cornea, usually nasally.
• The strongest environmental risk factor is chronic UV exposure, especially in tropical climates and outdoor workers.
• Modern understanding views pterygium as an active UV-related proliferative and inflammatory process, not merely passive degeneration.
• Visual impairment can occur from induced astigmatism well before the lesion reaches the visual axis.
• Stocker line is iron deposition just anterior to the pterygium head and does not reliably prove inactivity.
• A pinguecula does not cross the limbus; a pterygium does.
• A pseudopterygium follows trauma or inflammation and can occur at any limbal location.
• Atypical, leukoplakic, nodular, rapidly growing, or temporal lesions should raise concern for OSSN and may require biopsy.
• Lubricants and short courses of topical steroids can relieve symptoms but do not eliminate the pterygium.
• Surgery is indicated for progression, visually significant astigmatism, threatened visual axis, persistent symptoms, motility restriction, or significant cosmetic concern.
• Conjunctival autograft is the preferred technique for most primary pterygia because of its low recurrence rate.
• The bare sclera technique should generally be avoided because recurrence is high.
• MMC reduces recurrence but must be used judiciously because of potentially serious complications such as scleral melt.
• Amniotic membrane is useful when conjunctiva needs to be preserved, but for routine primary pterygium surgery it generally has a higher recurrence rate than conjunctival autograft.
• Recurrence occurs most commonly during the first postoperative year.
• A fixed 6-month steroid course is not required for every patient; postoperative anti-inflammatory therapy should be individualized.
• Continued UV-blocking eyewear and hats are important after surgery to reduce ongoing environmental exposure.

Ophthalmology – Pseudopapilledema

Basics

Description

Pseudopapilledema is apparent optic disc elevation that is not caused by increased intracranial pressure (ICP) and does not represent true optic disc edema.

Common causes include:

• Optic disc drusen (ODD)
• Congenitally crowded optic discs
• Tilted optic discs
• Hyperopic small discs
• Myelinated retinal nerve fibers
• Other congenital optic nerve head anomalies

The major clinical challenge is:

Distinguishing pseudopapilledema from true papilledema, because papilledema may indicate life-threatening intracranial disease.

⸻

Key Clinical Concept

Pseudopapilledema usually represents:

An elevated but structurally anomalous optic nerve head without active axoplasmic stasis from raised ICP.

Most patients are asymptomatic and have:

• Normal central vision
• Normal color vision
• Stable optic disc appearance

However, optic disc drusen can cause:

• Progressive visual field loss
• Peripapillary hemorrhage
• Rare vascular complications
• Rare choroidal neovascularization

⸻

Optic Disc Drusen

Optic disc drusen (ODD) are calcified or partially calcified extracellular deposits within the optic nerve head.

They are composed largely of:

• Mitochondrial and axoplasmic material
• Calcium
• Mucopolysaccharide/proteinaceous material

They may be:

• Buried
• Superficial

Buried drusen are especially common in younger patients and may closely mimic papilledema.

⸻

Pathophysiology of Optic Disc Drusen

The exact mechanism is incompletely understood.

A leading concept is:

Small/crowded optic nerve head → impaired axoplasmic transport → axonal degeneration → extracellular deposition → progressive calcification

Drusen tend to become:

• More visible
• More calcified

with age.

⸻

Epidemiology

ODD occur in roughly:

1–2% of the population

depending on the population and detection method.

They are frequently:

• Bilateral

but may be markedly asymmetric.

⸻

Genetics

Familial clustering occurs, but the older description of ODD as a simple:

Autosomal dominant disorder

is an oversimplification.

Current understanding suggests:

• Familial susceptibility
• Variable penetrance
• Multifactorial inheritance

Routine genetic testing is not indicated for isolated ODD.

⸻

Associated Conditions

ODD and pseudopapilledema have been reported with:

• Alagille syndrome
• Down syndrome
• Certain craniofacial disorders
• Retinitis pigmentosa and other retinal dystrophies in selected cases

The most important clinical association remains:

A congenitally crowded optic nerve head.

⸻

Clinical Presentation

Most patients are:

Asymptomatic

and pseudopapilledema is discovered incidentally.

Possible symptoms include:

• Transient visual obscurations
• Peripheral visual field loss
• Rare central visual loss

Symptoms alone cannot reliably distinguish pseudopapilledema from papilledema.

⸻

History

Ask specifically about symptoms suggesting raised ICP:

• Headache
• Nausea/vomiting
• Pulsatile tinnitus
• Transient visual obscurations
• Diplopia
• Recent weight gain
• Medication exposure associated with intracranial hypertension

Also ask about:

• Acute visual loss
• Color desaturation
• Eye pain
• Neurologic symptoms
• Previous optic disc photographs
• Family history of ODD

⸻

Physical Examination

Assess:

• Visual acuity
• Color vision
• Pupils
• Visual fields
• Ocular motility
• Blood pressure
• Dilated optic disc appearance

⸻

Typical Pseudopapilledema Appearance

Features favoring pseudopapilledema include:

• Small crowded disc
• Little or no physiologic cup
• Elevated disc surface
• Irregular or lumpy contour
• Visible superficial drusen
• Anomalous vessel branching
• No true disc hyperemia
• No widespread peripapillary hemorrhages
• No retinal/choroidal folds from raised ICP

⸻

Superficial Optic Disc Drusen

Visible drusen appear as:

• Yellow-white
• Refractile
• Lobulated deposits

often clustered around the disc margin.

They may be obvious on ophthalmoscopy.

⸻

Buried Optic Disc Drusen

Buried drusen may cause:

• Smooth or irregular disc elevation
• Blurred margins
• Apparent “swelling”

without visible calcific deposits.

These are particularly difficult to distinguish from mild papilledema.

⸻

Papilledema vs Pseudopapilledema

Features Favoring Papilledema

• Hyperemic disc
• True elevation of nerve fiber layer
• Obscuration of vessels crossing the disc margin
• Peripapillary hemorrhages
• Cotton-wool spots in severe cases
• Paton’s lines / peripapillary retinal folds
• Venous congestion
• Progressive disc swelling
• Symptoms/signs of raised ICP

Features Favoring Pseudopapilledema

• Small crowded disc
• Lumpy-bumpy contour
• Visible drusen
• Minimal hyperemia
• No significant venous congestion
• Stable appearance over time
• Structural evidence of buried drusen on imaging

⸻

Important Caution – Spontaneous Venous Pulsation

The presence of:

Spontaneous venous pulsation (SVP)

suggests that ICP is not markedly elevated at that moment.

However:

Absence of SVP does not diagnose papilledema, and presence of SVP does not absolutely exclude all forms of intracranial hypertension.

SVP is only one supportive sign.

⸻

Optical Coherence Tomography

Modern OCT is central to evaluating suspected pseudopapilledema.

Particularly useful techniques include:

• Enhanced-depth imaging OCT (EDI-OCT)
• Swept-source OCT
• Standard high-resolution optic nerve OCT

⸻

EDI-OCT Findings in Optic Disc Drusen

ODD typically appear as:

Hyporeflective core-like structures with hyperreflective margins

within the optic nerve head.

EDI-OCT is particularly useful for:

• Buried drusen
• Noncalcified drusen
• Pediatric patients

⸻

Modern Imaging Principle

EDI-OCT is generally the most useful structural imaging modality for detecting buried ODD.

This represents a major change from older teaching that emphasized CT or ultrasound.

⸻

Peripapillary Hyperreflective Ovoid Mass-Like Structures

OCT may reveal:

PHOMS

or peripapillary hyperreflective ovoid mass-like structures.

These appear as hyperreflective ovoid structures around the disc.

Important:

PHOMS are not the same as optic disc drusen.

They represent herniated/distended axons and may occur with:

• Papilledema
• ODD
• Tilted discs
• Myopia
• Other optic nerve abnormalities

Therefore PHOMS alone do not establish pseudopapilledema.

⸻

RNFL OCT

RNFL OCT may show:

• Thickened RNFL early from crowded anatomy
• Progressive RNFL thinning in longstanding ODD

Interpretation can be difficult because:

• Disc anatomy is abnormal
• Segmentation errors are common

⸻

Ganglion Cell Analysis

Macular:

• GCIPL
• GCC

may help identify chronic axonal loss and can be useful for:

• Baseline assessment
• Monitoring progression

⸻

Fundus Autofluorescence

Superficial calcified drusen often show:

Autofluorescence

and may be readily detected.

However:

• Deep buried drusen may not autofluoresce strongly

so a negative study does not exclude ODD.

⸻

B-Scan Ultrasonography

B-scan may show:

Highly reflective calcified deposits with acoustic shadowing

and is useful when drusen are sufficiently calcified.

Limitations:

• Less sensitive for small or noncalcified buried drusen
• Particularly limited in younger patients

⸻

CT

CT may demonstrate:

• Calcified optic disc drusen

but is not routinely recommended merely to diagnose pseudopapilledema because:

• Radiation exposure is unnecessary
• Small drusen may be missed
• OCT provides better structural information without ionizing radiation

⸻

Fluorescein Angiography

FA is rarely needed today but can be useful in difficult cases.

Papilledema

Typically shows:

• Early disc hyperfluorescence
• Late leakage

Optic Disc Drusen

May show:

• Nodular staining
• Autofluorescence
• Little or no true late leakage

⸻

Fundus Photography

Baseline photographs are extremely useful for:

• Documenting disc morphology
• Comparing future examinations
• Avoiding repeated unnecessary neurologic workups

⸻

Visual Fields

Formal perimetry is important because ODD can cause progressive peripheral field loss.

Common defects include:

• Enlarged blind spot
• Arcuate defects
• Nasal step
• Peripheral constriction
• Nerve fiber bundle defects

⸻

Visual Field Loss

Visual field defects become more common as drusen become:

• Superficial
• More calcified
• Associated with RNFL loss

Central visual acuity usually remains good.

⸻

Diagnosis

Diagnosis combines:

• Clinical appearance
• OCT
• Fundus autofluorescence
• B-scan when appropriate
• Visual fields

The overriding principle is:

Do not diagnose pseudopapilledema until true optic disc edema has been reasonably excluded.

⸻

Pediatric Considerations

Distinguishing buried drusen from mild papilledema is especially difficult in children because:

• Drusen are often deeply buried
• Calcification is incomplete
• Ultrasound/autofluorescence may be negative
• Crowded discs are common

EDI-OCT is particularly useful.

⸻

When Neuroimaging Is Still Required

If papilledema cannot be confidently excluded, proceed according to a papilledema workup rather than assuming pseudopapilledema.

Concerning features include:

• Significant headache
• Diplopia
• Pulsatile tinnitus
• Neurologic symptoms
• Progressive disc swelling
• Retinal/choroidal folds
• Marked hemorrhage
• Unexplained visual dysfunction

This may require:

• MRI brain/orbits
• MR venography
• Lumbar puncture after appropriate imaging

depending on the clinical scenario.

⸻

Differential Diagnosis

Important differentials include:

• True papilledema
• Optic neuritis
• Anterior ischemic optic neuropathy
• Neuroretinitis
• Infiltrative optic neuropathy
• Compressive optic neuropathy
• Optic nerve glioma
• Optic nerve sheath meningioma
• Sarcoidosis
• Leukemic/lymphomatous infiltration
• Posterior scleritis
• Leber hereditary optic neuropathy

⸻

Optic Disc Drusen vs Papilledema

This is the most important diagnostic distinction.

ODD

• Usually chronic
• Often asymptomatic
• Small crowded disc
• Drusen may be visible
• No true vessel obscuration from edema
• OCT reveals buried deposits
• No ICP elevation

Papilledema

• True optic disc edema
• Caused by increased ICP
• Often bilateral
• May have hemorrhage/venous congestion/folds
• Requires urgent etiologic investigation

⸻

ODD vs Optic Neuritis

Optic neuritis typically causes:

• Acute/subacute visual loss
• Dyschromatopsia
• RAPD
• Pain with eye movement

ODD generally causes:

• Preserved acuity
• Chronic/stable appearance
• Peripheral field defects rather than acute central loss

⸻

ODD vs NAION

ODD can predispose to:

Nonarteritic anterior ischemic optic neuropathy (NAION)

particularly in younger individuals with crowded discs.

NAION presents with:

• Acute painless visual loss
• New disc edema
• Corresponding field defect

A patient with known ODD can still develop genuine optic disc edema from NAION.

⸻

Treatment

Uncomplicated Optic Disc Drusen

There is:

No treatment that removes or dissolves optic disc drusen.

Management consists of:

• Observation
• Visual field monitoring
• OCT monitoring
• Patient education

⸻

IOP Lowering

Routine prophylactic IOP lowering solely because ODD is present is:

Not established standard therapy.

If the patient also has:

• Ocular hypertension
• Glaucoma

then treat according to normal glaucoma principles.

⸻

Choroidal Neovascularization

Rarely, ODD may be associated with:

Peripapillary choroidal neovascularization

especially in younger patients.

If visually significant, treatment may include:

Intravitreal anti-VEGF therapy

⸻

Peripapillary Hemorrhage

Small disc or peripapillary hemorrhages may occur from:

• Mechanical effects of drusen
• Peripapillary vascular disruption

These often resolve spontaneously.

However, hemorrhage should prompt careful assessment to exclude:

• CNV
• True disc edema
• Other optic neuropathy

⸻

Retinal Vascular Occlusion

Rare associations include:

• Central retinal vein occlusion
• Branch retinal vein occlusion
• Retinal artery occlusion

These require treatment according to the specific vascular disorder.

⸻

NAION

ODD is associated with an increased risk of:

NAION

especially in crowded optic nerves.

There is no proven therapy that reverses established NAION.

Management focuses on:

• Vascular risk factors
• Sleep apnea when relevant
• Blood pressure management
• Avoiding excessive nocturnal hypotension when possible

⸻

Follow-Up

Stable uncomplicated ODD can usually be followed:

Approximately annually

with:

• Visual acuity
• Pupils
• Optic disc examination
• Visual fields
• OCT RNFL/GCIPL

Frequency should increase if:

• Field loss is progressing
• RNFL loss is progressing
• New symptoms develop

⸻

Patient Education

Patients should know:

• Their discs may appear swollen to future clinicians
• They should mention their history of pseudopapilledema/ODD
• Baseline photographs or OCT records are valuable

They should seek reassessment for:

• Acute visual loss
• New field defect
• Persistent transient obscurations
• New neurologic symptoms

because known ODD does not protect against true papilledema or other optic neuropathies.

⸻

Prognosis

Overall prognosis is:

Excellent for central visual acuity

in most patients.

However, peripheral visual field loss may:

• Develop
• Progress slowly

over time.

⸻

Central Visual Loss

Significant central acuity loss is uncommon and should prompt evaluation for:

• NAION
• CNV
• Retinal vascular occlusion
• Another optic neuropathy

rather than being automatically attributed to drusen.

⸻

Complications

Potential complications include:

• Progressive visual field loss
• RNFL thinning
• Peripapillary hemorrhage
• NAION
• Peripapillary CNV
• Retinal vascular occlusion
• Rare central visual loss

⸻

Ophthalmology Pearls

• Pseudopapilledema is optic disc elevation without raised intracranial pressure or true optic disc edema.
• The most common important cause is optic disc drusen, especially buried ODD in children and young adults.
• ODD probably results from crowded optic nerve anatomy with impaired axoplasmic transport and secondary extracellular deposition/calcification.
• The older idea that optic disc drusen follow a simple autosomal dominant inheritance pattern is oversimplified; familial clustering exists, but inheritance is likely multifactorial with variable penetrance.
• EDI-OCT is the key modern test for buried optic disc drusen and is particularly useful in children.
• Superficial drusen may be detected by fundus autofluorescence; B-scan works best when deposits are sufficiently calcified.
• Routine CT is generally unnecessary because OCT provides better structural information without radiation.
• PHOMS are not optic disc drusen and can occur in both pseudopapilledema and true disc edema.
• The key distinction from papilledema is the absence of genuine disc edema from raised ICP; when doubt remains, investigate for papilledema rather than assuming pseudopapilledema.
• Presence or absence of spontaneous venous pulsation is supportive but not definitive.
• ODD commonly causes peripheral nerve-fiber-bundle visual field defects, while central acuity is usually preserved.
• Optic disc drusen require no specific medical treatment when uncomplicated.
• Routine IOP lowering is not indicated solely because ODD exists, although coexisting glaucoma or ocular hypertension should be treated normally.
• Important complications include progressive field loss, NAION, peripapillary hemorrhage, and rare peripapillary CNV.
• A patient with known ODD can still develop true papilledema, NAION, or another optic neuropathy; a prior diagnosis of pseudopapilledema should never be used to dismiss new neurologic or visual symptoms.
• Baseline disc photographs, OCT, and visual fields are highly useful for long-term comparison.

Ophthalmology – Pseudoexfoliation Syndrome

Basics

Description

Pseudoexfoliation syndrome (PXS), also called exfoliation syndrome (XFS), is an age-related systemic extracellular matrix disorder characterized by production and deposition of abnormal fibrillar pseudoexfoliative material within the anterior segment.

Deposits occur on structures including:

• Anterior lens capsule
• Pupillary margin
• Iris
• Ciliary body
• Zonules
• Corneal endothelium
• Trabecular meshwork

Its two major ophthalmic consequences are:

• Secondary open-angle glaucoma
• Zonular weakness complicating cataract surgery

When glaucomatous optic neuropathy develops, the condition is termed:

Pseudoexfoliative glaucoma / exfoliation glaucoma (PXG/XFG)

Key Clinical Concept

The classic examination finding is:

Gray-white pseudoexfoliative material on the anterior lens capsule, especially after dilation

combined with:

• Poor pupillary dilation
• Peripupillary iris transillumination
• Dense angle pigmentation
• Sampaolesi line
• Zonular weakness

PXG is often:

More aggressive than primary open-angle glaucoma (POAG)

with:

• Higher IOP
• Greater IOP fluctuation
• Faster progression
• More frequent need for surgery

Pseudoexfoliation vs True Exfoliation

These are different disorders.

Pseudoexfoliation

• Abnormal fibrillar extracellular material
• Associated with glaucoma and zonulopathy
• Usually older adults

True Exfoliation

• Delamination of the anterior lens capsule
• Historically associated with intense infrared exposure, such as glassblowing
• Does not represent the same fibrillopathy

Epidemiology

PXS is strongly age-related and is uncommon before:

50–60 years

Prevalence varies substantially among:

• Geographic regions
• Ethnic groups
• Populations

High prevalence has historically been reported in:

• Scandinavian countries
• Northern Europe

but PXS occurs worldwide.

Laterality

PXS is frequently:

• Bilateral
• Markedly asymmetric

A patient may appear clinically unilateral for years.

The fellow eye may already have subclinical disease even when classic deposits are absent.

Risk Factors

Important associations include:

• Increasing age
• Family history
• Certain ethnic/geographic populations
• Genetic susceptibility

Female predominance is reported in some populations, but this is not universal.

Genetics

The strongest genetic association is with:

LOXL1

not “LOL1.”

LOXL1 encodes lysyl oxidase-like 1, which participates in:

• Elastin formation
• Extracellular matrix maintenance

LOXL1 Important Principle

LOXL1 risk variants are:

• Very common in the general population
• Present in many people who never develop PXS

Therefore:

LOXL1 testing has no routine clinical diagnostic or predictive role.

PXS is considered:

Multifactorial

with both genetic and environmental contributions.

Other Genetic Associations

Additional genes and pathways involving:

• Extracellular matrix regulation
• Oxidative stress
• Elastic fiber biology

have been implicated.

However, routine genetic testing is not currently indicated.

Pathophysiology

Pseudoexfoliative material is produced by several anterior segment tissues and deposited throughout the eye.

The abnormal material contains:

• Elastic microfibrillar components
• Glycoproteins
• Proteoglycans
• Basement membrane-related proteins

Altered extracellular matrix regulation and oxidative stress contribute to disease.

Glaucoma Mechanism

The principal glaucoma mechanism is:

Open-angle outflow obstruction

due to accumulation of:

• Pseudoexfoliative material
• Iris pigment
• Cellular debris

within the trabecular meshwork and juxtacanalicular tissue.

This produces:

• Increased outflow resistance
• Elevated IOP
• Large diurnal IOP fluctuations

Why Pigment Is Increased

Pigment liberation results from:

• Iris rubbing against the lens and zonules
• Degenerative iris changes
• Pupillary movement

This produces:

• Trabecular pigmentation
• Sampaolesi line
• Pupillary margin changes

Angle Closure

Although PXG is usually an:

Open-angle glaucoma

angle closure can also occur because of:

• Zonular weakness
• Anterior lens displacement
• Lens subluxation
• Pupillary block
• Progressive angle narrowing with age

Therefore:

Gonioscopy is essential.

Zonular Pathology

Pseudoexfoliative material accumulates on and around the zonules.

This leads to:

• Zonular fragility
• Phacodonesis
• Iridodonesis
• Lens subluxation
• Intraoperative zonular dialysis
• Late IOL–capsular bag dislocation

This is one of the most important practical consequences of PXS.

Corneal Changes

PXS may affect the corneal endothelium and is associated with:

• Reduced endothelial cell density
• Abnormal endothelial morphology
• Pigment deposition
• Increased risk of postoperative corneal edema

Severe endothelial compromise may occasionally cause:

• Corneal decompensation

Systemic Nature

Pseudoexfoliative material has been identified histologically in extraocular tissues.

Associations with:

• Cardiovascular disease
• Cerebrovascular disease
• Hearing impairment
• Vascular dysfunction

have been reported.

However:

The clinical significance of these systemic associations remains inconsistent, and routine systemic screening solely because of PXS is not established.

History

Most patients are:

Asymptomatic

until they develop:

• Glaucoma
• Cataract
• Lens instability

Ask about:

• Family history of glaucoma
• Previous high IOP
• Cataract surgery
• Trauma
• Fluctuating vision
• Progressive visual field loss

Slit-Lamp Examination

Typical findings include:

• Pseudoexfoliative material on anterior lens capsule
• Flakes at pupillary margin
• Poor pupillary dilation
• Loss of pupillary ruff
• Peripupillary transillumination
• Pigment on corneal endothelium
• Phacodonesis
• Iridodonesis

Classic Lens-Capsule Pattern

After dilation, the anterior lens capsule may show three zones:

1. Central gray-white disc
2. Intermediate clear zone
3. Peripheral granular ring of pseudoexfoliative material

The clear zone forms because the moving iris rubs material from the capsule.

This is a classic exam finding.

Pupillary Margin

Pseudoexfoliative material may accumulate as:

• White dandruff-like flakes

along the:

Pupillary ruff

Associated findings include:

• Loss of pupillary ruff
• Poor dilation
• Iris sphincter atrophy

Iris Transillumination

Typical defects are:

Peripupillary / pupillary-border transillumination defects

producing a moth-eaten appearance.

This helps distinguish PXS from pigment dispersion syndrome, where transillumination defects are usually:

Radial and midperipheral.

Poor Mydriasis

Poor dilation is common because of:

• Iris stromal degeneration
• Sphincter dysfunction
• Posterior synechiae in selected cases
• Mechanical changes associated with PXS

This is an important cataract-surgery risk factor.

Corneal Endothelium

Possible findings include:

• Scattered pseudoexfoliative deposits
• Pigment
• Endothelial changes

A Krukenberg spindle can occasionally occur but is much more characteristic of pigment dispersion.

Gonioscopy

Typical findings include:

• Open angle
• Increased trabecular pigmentation
• Often patchy or asymmetric pigmentation
• Sampaolesi line

Sampaolesi Line

A Sampaolesi line is pigment deposited anterior to:

Schwalbe line

It is commonly seen in:

• PXS
• Pigment dispersion

and is not pathognomonic.

Intraocular Pressure

IOP may be:

• Normal
• Intermittently elevated
• Persistently elevated

PXG often produces:

• Higher peak IOP
• Greater diurnal fluctuation
• More asymmetry between eyes

than POAG.

Pseudoexfoliation Syndrome vs Pseudoexfoliation Glaucoma

PXS

• Pseudoexfoliative material present
• No definite glaucomatous optic neuropathy required

PXG

• PXS findings
• Elevated IOP often present
• Glaucomatous optic nerve/RNFL damage
• Corresponding visual field loss

Optic Nerve Evaluation

Assess for:

• Neuroretinal rim thinning
• Focal notching
• RNFL defects
• Disc hemorrhage
• Increased cupping
• Inter-eye asymmetry

OCT

Obtain:

• Peripapillary RNFL
• Macular GCIPL/GCC
• Optic nerve head analysis

Progression analysis is valuable because PXG may progress rapidly.

Visual Fields

Automated perimetry may demonstrate:

• Nasal step
• Paracentral scotoma
• Arcuate defects
• Advanced field constriction

Because progression can be fast, field testing may need to be more frequent than in stable mild POAG.

Pachymetry

Measure central corneal thickness as part of glaucoma assessment.

CCT should influence:

• Risk interpretation
• Understanding of measured IOP

but should not be used with a simplistic numerical IOP “correction formula.”

Gonioscopy Before Dilation

Gonioscopy is useful before cataract surgery and glaucoma management to identify:

• Open vs narrow angle
• Degree of pigmentation
• PAS
• Lens-related angle crowding

Differential Diagnosis

Important differentials include:

• Pigment dispersion syndrome
• Primary open-angle glaucoma
• Chronic angle-closure glaucoma
• Uveitic glaucoma
• True exfoliation of lens capsule
• Pigment from previous trauma or surgery

PXS vs Pigment Dispersion Syndrome

PXS

Typically:

• Older patient
• Poor dilation
• Peripupillary transillumination
• Pseudoexfoliative material
• Zonular weakness
• Patchier angle pigment

Pigment Dispersion

Typically:

• Younger myope
• Deep anterior chamber
• Radial midperipheral transillumination
• Krukenberg spindle
• Dense homogeneous trabecular pigmentation
• No characteristic progressive zonulopathy

PXS vs POAG

POAG lacks:

• Pseudoexfoliative deposits
• Peripupillary transillumination pattern
• Zonular weakness
• Characteristic poor dilation

PXG often has:

Higher and more fluctuating IOP than typical POAG.

Treatment – PXS Without Glaucoma

If there is:

• Normal IOP
• Normal optic nerve
• Normal OCT
• Normal visual field

treatment is usually:

Observation

with periodic glaucoma surveillance.

Ocular Hypertension in PXS

PXS with elevated IOP carries a greater glaucoma risk than uncomplicated ocular hypertension.

Consider:

• Closer monitoring
• Lower threshold for treatment

depending on:

• IOP level
• Age
• Optic nerve
• CCT
• Family history
• Follow-up reliability

Treatment of PXG

Treatment aims to achieve a target IOP sufficient to prevent progression.

Because PXG may progress faster than POAG:

A relatively low target IOP may be necessary.

Medical Therapy

Common medications include:

• Prostaglandin analogs
• Beta-blockers
• Carbonic anhydrase inhibitors
• Alpha-2 agonists
• Rho-kinase inhibitors where available
• Fixed combinations

Prostaglandin Analogs

Prostaglandin analogs are commonly effective first-line therapy because of:

• Strong IOP reduction
• Once-daily dosing
• Good adherence profile

Selective Laser Trabeculoplasty

SLT is highly effective in many eyes with PXG.

Advantages include:

• Strong IOP response
• Avoidance of daily medications
• Suitability as primary or adjunctive treatment

SLT Considerations

The trabecular meshwork in PXS may be heavily pigmented.

Therefore:

• Start with appropriate/lower energy
• Titrate carefully
• Monitor for post-laser IOP spike

The initial response may be excellent but can diminish with time.

Important Modern Point

SLT is no longer merely a “second-line” treatment.

It may reasonably be used as:

First-line IOP-lowering therapy

in appropriate open-angle PXG.

Cataract Surgery

Cataract surgery in PXS requires special planning because of:

• Poor dilation
• Weak zonules
• Dense nucleus
• Increased risk of vitreous loss
• Increased postoperative inflammation

Preoperative Cataract Assessment

Look specifically for:

• Phacodonesis
• Iridodonesis
• Lens decentration
• Asymmetric anterior chamber depth
• Previous zonular dialysis
• Poor mydriasis
• Endothelial compromise

Intraoperative Risks

Possible complications include:

• Zonular dialysis
• Capsular rupture
• Vitreous loss
• Dropped lens material
• Capsular instability
• Iris trauma
• Corneal endothelial injury

Small-Pupil Management

Options include:

• Intracameral mydriatics
• Viscomydriasis
• Iris hooks
• Pupil expansion ring

Mechanical expansion should be used when necessary rather than forcing surgery through an inadequate pupil.

Zonular Support

Depending on zonular status, options include:

• Capsular tension ring (CTR)
• Capsular hooks
• Capsular tension segment
• Scleral fixation strategies

Capsular Tension Ring

A CTR can redistribute zonular forces in selected eyes with:

• Mild–moderate generalized zonular weakness

However:

A CTR does not guarantee long-term bag stability.

Late IOL–capsular bag complex dislocation can still occur.

Severe Zonular Weakness

With major zonular loss, more advanced support may be required, such as:

• Capsular tension segment
• Scleral-fixated capsular device
• Alternative IOL fixation

An experienced anterior segment surgeon is often appropriate.

Late IOL–Bag Complex Dislocation

One of the classic late complications of PXS is:

Delayed spontaneous dislocation of the entire IOL–capsular bag complex

often years after apparently uncomplicated cataract surgery.

This occurs because zonular degeneration continues after surgery.

Cataract Surgery Does Not Cure PXS

Removing the lens eliminates the classic lens-capsule deposits but:

Pseudoexfoliation is a systemic/anterior segment fibrillopathy and does not disappear after cataract extraction.

Glaucoma and zonular complications may still occur.

Glaucoma Surgery

If medications and SLT do not achieve target IOP, options include:

• Trabeculectomy
• Glaucoma drainage device
• Selected MIGS procedures
• Cyclophotocoagulation in refractory disease

Trabeculectomy

Trabeculectomy can achieve:

• Low target IOP

and remains important in:

• Advanced PXG
• Rapid progression
• Eyes requiring substantial pressure lowering

Glaucoma Drainage Devices

Tube shunts are useful when:

• Trabeculectomy is likely to fail
• Prior filtering surgery has failed
• Conjunctival/scarring factors favor a tube

MIGS

MIGS may be considered in:

• Mild to moderate PXG
• Particularly when combined with cataract surgery

However, for advanced disease requiring very low IOP:

MIGS may be insufficient.

Cyclophotocoagulation

Cyclodestructive procedures may be considered in:

• Refractory glaucoma
• Eyes with poor visual potential
• Selected seeing eyes using modern controlled techniques

Routine Laboratory Testing

Routine laboratory evaluation for:

• Homocysteine
• Vitamin levels

is not recommended solely because PXS is present.

Historical reports of hyperhomocysteinemia have not established a role for routine screening or supplementation.

Systemic Screening

There is currently no standard recommendation for routine:

• Cardiac imaging
• Vascular screening
• Hearing testing

solely because of PXS.

Systemic evaluation should be based on ordinary clinical indications.

Follow-Up – PXS Without Glaucoma

Patients with PXS but no glaucoma generally require:

At least annual ophthalmic follow-up

with:

• IOP
• Optic nerve evaluation
• Gonioscopy when appropriate
• OCT/visual fields according to risk

Closer follow-up is appropriate if:

• IOP is elevated
• Disease is markedly asymmetric
• Optic nerve is suspicious

Follow-Up – PXG

PXG should be monitored according to severity.

Visits may range from approximately:

• Every few months in active/advanced disease
• Less frequently when mild and stable

Monitor:

• IOP
• Optic nerve
• OCT
• Visual fields
• Treatment adherence
• Cataract/lens stability

Prognosis

PXS without glaucoma may remain stable for many years.

Once glaucoma develops:

PXG often behaves more aggressively than POAG.

Poor prognostic features include:

• Very high IOP
• Marked IOP fluctuation
• Advanced damage at diagnosis
• Poor follow-up
• Inadequate treatment

Complications

Important complications include:

• Pseudoexfoliative glaucoma
• Rapid glaucomatous field loss
• Poor pupillary dilation
• Zonular weakness
• Lens subluxation
• Cataract-surgery complications
• Late IOL–bag dislocation
• Corneal endothelial decompensation
• Chronic angle closure in selected eyes

Ophthalmology Pearls

• Pseudoexfoliation syndrome is an age-related fibrillopathy with abnormal extracellular material deposited on the lens, iris, zonules, corneal endothelium, and trabecular meshwork.
• The classic anterior lens appearance is central plaque + clear intermediate zone + peripheral granular ring after dilation.
• Look for poor dilation, peripupillary transillumination defects, loss of pupillary ruff, dense angle pigmentation, and Sampaolesi line.
• LOXL1 is the strongest genetic association, but routine genetic testing is not clinically useful.
• PXS is often bilateral but strikingly asymmetric.
• The major complications are glaucoma and zonular weakness.
• PXG is usually an open-angle glaucoma with higher IOP, greater fluctuation, and faster progression than typical POAG.
• SLT can be an effective first-line or adjunctive therapy, but use cautious energy in heavily pigmented angles because of post-laser IOP spikes.
• Cataract surgery is more difficult because of small pupil and weak zonules.
• A CTR can support the capsular bag but does not eliminate the risk of late IOL–bag complex dislocation.
• Cataract extraction does not cure pseudoexfoliation; glaucoma and zonular degeneration may continue afterward.
• Peripupillary transillumination favors PXS, whereas radial midperipheral transillumination favors pigment dispersion syndrome.
• Routine homocysteine testing or vitamin supplementation is not recommended solely because of PXS.
• Patients with PXS require long-term surveillance because conversion from apparently uncomplicated PXS to ocular hypertension or glaucoma can occur over time.

Ophthalmology – Primary Optic Nerve Sheath Meningioma

Basics

Description

Optic nerve sheath meningioma (ONSM) is a usually benign, slow-growing meningioma arising from the arachnoid cap cells of the meninges surrounding the optic nerve.

It produces a chronic compressive optic neuropathy through:

• Direct compression of the optic nerve
• Compromise of the pial vascular supply
• Compression of the central retinal venous circulation

The classic clinical pattern is:

Slowly progressive, painless, unilateral visual loss in a middle-aged adult

with characteristic enhancement around the optic nerve on orbital imaging.

Primary vs Secondary ONSM

Primary ONSM

Arises directly from the:

• Intraorbital optic nerve sheath
• Optic canalicular sheath

This is the classic form.

Secondary Optic Nerve Sheath Involvement

A meningioma arising elsewhere, particularly:

• Planum sphenoidale
• Tuberculum sellae
• Sphenoid wing

may secondarily extend along or compress the optic nerve.

These lesions have a different surgical and neuro-ophthalmic context.

Epidemiology

ONSM is uncommon.

It accounts for approximately:

• 1–2% of meningiomas
• A small proportion of orbital tumors

Most cases are:

• Unilateral
• Sporadic

Typical age at diagnosis:

Middle adulthood

with a female predominance.

Pediatric ONSM

ONSM is uncommon in children.

When diagnosed in a child or young adult, consider:

NF2-related schwannomatosis

formerly called neurofibromatosis type 2.

Pediatric ONSM may be:

• Bilateral
• Multifocal
• More strongly associated with an underlying tumor-predisposition syndrome

Genetics

Most sporadic ONSMs are not inherited.

Meningiomas frequently show alterations involving:

Chromosome 22 and the NF2 gene

When associated with NF2-related schwannomatosis, inheritance is:

Autosomal dominant

although de novo variants are common.

Pathophysiology

The tumor grows circumferentially around the optic nerve within its meningeal sheath.

Visual loss results from:

• Chronic axonal compression
• Ischemia of the optic nerve
• Disturbance of pial circulation
• Secondary venous outflow obstruction

Because the tumor often encases rather than directly invades the optic nerve, modern radiotherapy can control growth while preserving useful vision in many patients.

Clinical Presentation

The most common symptom is:

Slowly progressive painless visual loss

usually occurring over:

• Months
• Years

Other symptoms may include:

• Dyschromatopsia
• Visual field loss
• Relative afferent pupillary defect
• Proptosis
• Diplopia
• Transient visual obscurations

Visual Acuity

Visual acuity may range from:

• Normal or near-normal early
• Mildly reduced
• Profoundly reduced in advanced disease

Visual field and color vision abnormalities may precede major acuity loss.

Color Vision

Color vision is frequently reduced early because of:

Optic nerve dysfunction

and may be disproportionately impaired relative to Snellen acuity.

Relative Afferent Pupillary Defect

A RAPD is expected when disease is:

• Unilateral
• Markedly asymmetric

unless optic nerve function is profoundly reduced bilaterally.

Visual Field Defects

Possible field defects include:

• Central scotoma
• Cecocentral scotoma
• Arcuate defects
• Altitudinal defects
• Peripheral constriction

There is no single pathognomonic field pattern.

Serial perimetry is particularly useful for:

Monitoring progression.

Optic Disc Appearance

The optic disc may be:

• Normal
• Edematous
• Pale
• Atrophic

depending on:

• Tumor location
• Duration
• Degree of axonal damage

Optic Disc Edema

More anterior tumors may cause:

• Disc edema
• Venous congestion

because compression occurs closer to the globe.

Optic Atrophy

Posterior or chronic lesions more often produce:

Optic disc pallor

with corresponding:

• RNFL thinning
• Ganglion cell loss

Optociliary Shunt Vessels

A classic finding is:

Optociliary shunt vessels

These are collateral vessels on the optic disc connecting:

• Retinal venous circulation
• Choroidal circulation

They develop because chronic optic nerve sheath compression impairs normal venous drainage.

Classic Triad

The historical triad is:

1. Progressive visual loss
2. Optic atrophy
3. Optociliary shunt vessels

This combination is highly suggestive of ONSM but:

Not pathognomonic.

Proptosis

Proptosis may occur when the tumor becomes sufficiently large within the orbit.

It is typically:

• Axial
• Slowly progressive

because the optic nerve occupies the intraconal space.

Ocular Motility

Diplopia or motility restriction may occur because of:

• Mass effect
• Mechanical displacement
• Advanced orbital involvement

but is usually not an early feature.

Diagnosis

Diagnosis is usually based on:

• Characteristic neuro-ophthalmic findings
• High-quality orbital MRI

Biopsy is generally unnecessary.

MRI – Investigation of Choice

The preferred imaging study is:

MRI of the brain and orbits with and without contrast

using:

• Thin orbital sections
• Fat-suppressed postcontrast T1 imaging
• Axial and coronal views

Characteristic MRI Findings

Typical findings include:

• Tubular enlargement around optic nerve
• Fusiform sheath enlargement
• Intense enhancement of the tumor
• Relative nonenhancement of the central optic nerve

This produces the classic:

Tram-track sign

on axial imaging.

Doughnut Sign

On coronal imaging, enhancing tumor surrounding the relatively less enhancing optic nerve may produce a:

Doughnut sign

or ring-like appearance.

Imaging Morphology

ONSM may appear:

• Tubular
• Fusiform
• Globular
• Focal

Tumor may extend through:

• Optic canal
• Orbital apex

and occasionally intracranially.

CT

Thin-section CT is particularly useful for detecting:

• Calcification
• Optic canal enlargement
• Hyperostosis

Calcification strongly supports a meningioma in the appropriate clinical setting.

MRI remains superior for:

• Soft tissue
• Optic nerve
• Intracranial extension

OCT

OCT is increasingly valuable for monitoring ONSM.

Assess:

• Peripapillary RNFL
• Macular ganglion cell complex / GCIPL

Progressive thinning reflects:

Axonal loss

and may help quantify chronic optic neuropathy.

Important OCT Principle

Severe preexisting:

• RNFL thinning
• GCIPL loss

suggests limited potential for visual recovery even if the tumor is successfully controlled.

Radiotherapy primarily aims to:

Preserve remaining function

rather than regenerate lost axons.

Visual Fields

Formal automated perimetry should be performed serially when vision permits.

It is useful for:

• Baseline documentation
• Detecting progression
• Assessing response after treatment

Biopsy

Biopsy is:

Rarely indicated

because characteristic MRI findings are usually sufficient and surgery around the optic nerve carries substantial visual risk.

When Biopsy May Be Considered

Biopsy may be considered when:

• Imaging is atypical
• Rapid progression suggests another disease
• Malignancy is suspected
• Inflammatory/infiltrative disease cannot be excluded

Even then, biopsy should be approached cautiously.

Why Biopsy Is Avoided

The optic nerve blood supply is intimately associated with:

• Meningeal vessels
• Pial vessels
• Tumor sheath

Surgical manipulation can cause:

• Ischemia
• Direct optic nerve injury

with permanent loss of vision.

Differential Diagnosis

Important differentials include:

• Optic pathway glioma
• Optic perineuritis
• Sarcoidosis
• Lymphoma
• Metastatic disease
• IgG4-related orbital disease
• Idiopathic orbital inflammation
• Optic neuritis
• Leukemic infiltration
• Other orbital tumors

ONSM vs Optic Nerve Glioma

ONSM

Typically:

• Middle-aged adult
• Female predominance
• Sheath enhancement around nerve
• Tram-track appearance
• Calcification possible
• Optociliary shunt vessels possible

Optic Pathway Glioma

Typically:

• Childhood
• NF1 association
• Fusiform enlargement of the optic nerve itself
• Less characteristic sheath-type enhancement

ONSM vs Optic Perineuritis

Optic perineuritis may also produce:

• Perineural enhancement
• Tram-track appearance

but usually has a different clinical setting.

Features favoring perineuritis include:

• More acute/subacute symptoms
• Orbital pain
• Inflammatory disease
• Steroid responsiveness

ONSM usually causes:

Slow, painless progression.

ONSM vs Optic Neuritis

Typical optic neuritis usually causes:

• Acute/subacute visual loss
• Pain with eye movement
• Dyschromatopsia
• Often younger age
• Intraneural rather than sheath-predominant enhancement

ONSM generally progresses much more slowly.

ONSM vs Sarcoidosis